Medizinische Universität Graz - Research portal
Stadlbauer-Köllner Vanessa |
Presentations at scientific and public conferences
Figueiras, R; Vagueiro, S; Kay, R; Persia, E; Davidson, B; Ferreira, C; Stadlbauer, V; Pinato, DJ; Arsène, P; Schmitt, K; Dias, T
NOVEL MULTIOMICS BIOMARKER SIGNATURE DERIVED FROM BLOOD CIRCULATING HEPATOCYTE-EXTRACELLULAR VESICLES FOR THE EARLY DETECTION OF HCC
HEPATOLOGY. 2024; 80: S1995-S1996.-The Liver Meeting; NOV 15-19, 2024; San Diego, USA.
[Oral Communication]
Web of Science
Fürst, S; Schwarzl, J; Gulden, L; Woltsche, J; Horvath, A; Zügner, E; Magnes, C; Stadlbauer, V;
Acute kidney injury in liver cirrhosis: Combining microbiome and metabolome in the search for biomarkers.
ÖGGH Jahrestagung; JUN 12-15, 2024; Salzburg, AUSTRIA;. 2024.
[Poster]
Fürst, S; Schwarzl, J; Traub, J; Gulden, L; Woltsche, J; Horvath, A; Stadlbauer, V;
Malnutrition in liver cirrhosis: can screening tools predict outcome.
ÖGGH Jahrestagung; JUN 12-15 2024; Salzburg, AUSTRIA;. 2024.
[Poster]
Fürst, S; Traub, J; Schwarzl, J; Gulden, L; Woltsche, J; Horvath, A; Stadlbauer, V
Validation of an easy-to-use malnutrition screening in cirrhosis to predict outcome
J HEPATOL. Abstracts. 2024; 80: S229-S229.-EASL Congress; JUN 5-8, 2024; Milan, ITALY.
[Poster]
Web of Science
Haller, R; Hazia, O; Horvath, A; Stadlbauer, V
Nitrogen recycling by the gut microbiota in sarcopenia
10th Theodor Escherich Symposium 2024; JÄN 18 - 19; Graz, AUSTRIA. 2024.
[Poster]
Haller, R; Hazia, O; Traub, J; Horvath, A; Stadlbauer, V
Nitrogen recycling by the gut microbiome in sarcopenia
J HEPATOL. Abstracts. 2024; 80: S284-S284.-EASL Congress; JUN 5-8, 2024; Milan, ITALY.
[Poster]
Web of Science
Haller, R; Hazia, O; Traub, J; Horvath, A; Stadlbauer, V
Nitrogen recycling by the gut microbiome in sarcopenia.
Z Gastroenterol 2024
. 2024; 62(05)(e495):-57. ÖGGH Jahrestagung; JUN. 12-15, 2024; Salzburg, AUSTRIA;.
[Poster]
FullText
Horvath, A; Balazs, I; Feldbacher, N; Kofler, S; Haller, R; Pacher-Deutsch, Ch; Stadlbauer, V
Plastic in Research - Reduction by Redesign
3rd microONE Summit; NOV, 29, 2024; Graz, AUSTRIA. 2024.
[Poster]
Horvath, A; Brunner, D; Stiegler; P, Stadlbauer, V
Humoral immune system improves after liver transplantation
Z Gastroenterol 2024; 62: e477–e514. 2024; -Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; Jun, 14-15, 2024; Salzburg, AUSTRIA.
[Poster]
FullText
Horvath, A; Feldbacher, N; Stadlbauer, V
THE BENEFICIAL EFFECT OF A PROBIOTIC INTERVENTION ON QUALITY OF SLEEP - A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY.
DOI: 10.26355/mhd_20249_1023. 2024; -EHMSG – 37th International Workshop on Helicobacter & Microbiota in Inflammation & Cancer; SEP, 12-14, 2024; Porto, PORTUGAL.
[Oral Communication]
Horvath, A; Feldbacher, N; Stadlbauer, V
Probiotic intervention improves quality of sleep
Z Gastroenterol 2024; 62: e477–e514. 2024; -Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; Jun, 14-15, 2024; Salzburg, AUSTRIA.
[Poster]
FullText
Horvath, A; Feldbacher, N; Stadlbauer, V
Probiotic intervention improves quality of sleep - a randomized, double-blind, placebo-controlled, telemedical study
uegjournal, Volume 12, Issue S8, P0339. 2024; -UEGweek; OCT, 12 -15, 2024; Vienna, AUSTRIA.
[Poster]
Horvath, A; Fledbacher, N; Stadlbauer, V
Probiotic intervention improves quality of sleep
IBS Days; JUN, 17-19, 2024; Bologna, ITALY. 2024.
[Poster]
Pacher-Deutsch, C; Horvath, A; Stadlbauer, V
Raising awareness: Difficulties of plastic fasting
3rd microONE Summit on Microplastics and Health; 29.11.2024; Graz. 2024.
[Poster]
Pacher-Deutsch, C; Schweighofer, N; Hanemaaijer, M; Marut, W; Žukauskaitė, K; Horvath, A; Stadlbauer, V
The Microplastic Crisis: Role of Bacteria in Fighting Microplastic Effects in the Digestive System - A Comprehensive Literature Review
3rd microONE Summit on Microplastics and Health; 29.11.2024; Graz. 2024.
[Poster]
Pacher-Deutsch, C; Žukauskaitė, K; Erdogan, C; Nepel, M; Kogler, L; Habisch, H; Ducoli, S; Federici, S; Madl, T; Pichler, V; Horvath, A; Stadlbauer, V
The Influence of true-to-life Microplastic Particles on the Human Gut Microbiome – A Series of Bioreactor Experiments
3rd microONE Summit on Microplastics and Health; 29.11.2024; Graz. 2024.
[Poster]
Stadlbauer, V
Das Mikrobiom im hepatobiliären Formenkreis
Klinischer Abend AVT; APR 9, 2024; 2024.
[Oral Communication]
Stadlbauer, V
AKUTE HEPATISCHE PORPHYRIEN IM FOKUS: DIAGNOSE UND BEHANDLUNG AUS SICHT DER GYNÄKOLOGIE
Interne Fortbildung LKH Graz II Stabdort West; FEB 27, 2024; Graz. 2024.
[Oral Communication]
Stadlbauer, V
"LEAKY GUT" – WHAT IS IT?
HOW CAN WE MEASURE IT?
Immundiagnostik Fachtagung; JAN 10, 2024; online. 2024.
[Oral Communication]
Stadlbauer, V
Mikrobiom und Immunkompetenz
Gesellschaft der Salzburg Ärztinnen und Ärzte; MAY 30- Jun 3, 2024; Köln. 2024.
[Oral Communication]
Stadlbauer, V
Mikrobiom und Schlafqualität
Jahrentagung der ÖPROM; NOV 30, 2024; Wien. 2024.
[Oral Communication]
Stadlbauer, V
Erhöhte Leberwerte in der Schwangerschaft
Jahrestagung der ÖGIM; SEP 18-20, 2024; Salzburg. 2024.
[Oral Communication]
Stadlbauer, V
Microbiome and metabolic syndrome: Chicken and/or egg
UEG Week; OCT 12-15, 2024; Wien. 2024.
[Oral Communication]
Stadlbauer, V
Wo haben Probiotika einen belegbaren klinischen Stellenwert
Seminar "Medikamentöse Therapie bei GI-Erkrankungen"; MAR 22, 2024; 2024.
[Oral Communication]
Stadlbauer, V
Wo haben probiotische Nahrungsergänzungs- und Arzneimittel einen belegbaren klinischen Stellenwert?
Klinikfortbildung LKH Graz II Standort West; JAN 30, 2024; Innsbruck. 2024.
[Oral Communication]
Stadlbauer, V
Mikrobiomdiagnostik in der klinischen Anwendung - Pro
DGIM; APR 16, 2024; Mannheim. 2024.
[Oral Communication]
FullText
Stadlbauer, V
Ernährung und Sarkopenie: Risikoeinstufung und Management
ÖGGH Lebertrabnsplantationskurs; FEB 1-2, 2024; Innsbruck. 2024.
[Oral Communication]
Stadlbauer, V
Leberkoma
ICU@Liver; JAN 11, 2024; Wien. 2024.
[Oral Communication]
Stadlbauer, V
Diagnose der Sarkopenie
Präsymposium Task Force Sarcopenie; MAR 15, 2024; 2024.
[Oral Communication]
Stadlbauer, V
Die Leber auf der Intensivstation
ÖGARI ; MAR 18, 2024; 2024.
[Oral Communication]
Stadlbauer, V
Mikrobiota und Lebererkrankungen
Microbiota-Meeting 2024 -Microbiota Interactions; 23 Nov 2024; 2024.
[Oral Communication]
Stadlbauer, V
AKUTE HEPATISCHE PORPHYRIEN IM FOKUS: DIAGNOSE UND BEHANDLUNG AUS SICHT DER GYNÄKOLOGIE
FOMF Gynäkologie; FEB 21, 2024; online Wien. 2024.
[Oral Communication]
Stadlbauer, V
Das Mikrobiom
Gesellschaft der Salzburg Ärztinnen und Ärzte; APR 17, 2024; Salzburg. 2024.
[Oral Communication]
Stadlbauer, V
Das Mikrobiom
Nissle Gesellschaft; SEP 4, 2024; Köln. 2024.
[Oral Communication]
Stadlbauer, V
Die Darm-Leber-Achse als therapeutisches Ziel in der Hepatologie
Nissle Gesellschaft; SEP 4, 2024; Köln. 2024.
[Oral Communication]
Stadlbauer, V
Mikrobiomforschung Status quo & quo vadis
HTS Cluster Netzwerktreffen; MAR 19, 2024; 2024.
[Oral Communication]
Stadlbauer, V
Zu jedem Antibiotikum ein Probiotikum? Fakten und Diskussionen
DEPROM; FEB23-24, 2024; Berlin. 2024.
[Oral Communication]
Stadlbauer, V
The Core Human Microbiome: Does It Exist?
MICROBE Workshop; JAN 15, 2024; München. 2024.
[Oral Communication]
Stadlbauer, V
Prä- und Probiotika
ÖÄK Diplom ernährungsmedizin; JAN 12, 2024; Wien. 2024.
[Oral Communication]
Stadlbauer, V
Lebertransplantation: Zu gut, zu schlecht, oder jetzt erst recht?
Frühling der Hepatologie; MAR 16, 2024; 2024.
[Oral Communication]
Stauber, RE; Rainer, F; Stadlbauer, V; Avian, A; Scharnagl, H; Marsche, G
A HDL-based prognostic model performs better than MELD in chronic liver failure
J HEPATOL. 2024; 80: S383-S383.-EASL Congress; JUN 5-8, 2024; Milan, ITALY.
[Poster]
Web of Science
Zukauskaite, K; Pacher, C; Tripolt, S; Balazs, I;, Horvath, A; Stadlbauer, V;
Optimizing in vitro modeling of the human gut: exploring microbial dynamics in intestinal health and disease.
Theodor Escherich Symposium; JAN 18-19, 2024; Graz, AUSTRIA. 2024.
[Poster]
Aliwa, B; Horvath, A; Feldbacher, N; Traub, J; Fauler, G; Stadlbauer, V
Altered gut microbiome and stool bile acids in sarcopenia in cirrhosis
J HEPATOL. 2023; 78: S346-S346.
[Poster]
Web of Science
Egger, M; Horvath, A; Prüller, F; Fickert, P; Prattes, J; Krause, R; Hoenigl, M; Stadlbauer, V
Fungal translocation measured by serum 1,3-Beta-D-glucan is associated with severity and outcome of liver cirrhosis - a pilot study
. 2023; ( ): - .-The 33rd European Congress of Clinical Microbiology & Infectious Diseases; APR 15-18; 2023; Copenhagen, DENMARK. (ISBN: )
[Poster]
FullText
Haller, R; Fürst, S; Woltsche, J; Gulden, L; Schwarzl, J; Traub, J; Feldbacher, N; Aliwa, B; Madl, T; Fauler, G; Horvath, A; Stadlbauer, V
Phascolarctobacterium as a predictor for survival in cirrhotic patients
J HEPATOL. 2023; 78: S354-S354.
[Poster]
Web of Science
Haller, R; Fürst, S; Woltsche, J; Gulden, L; Schwarzl, J; Traub, J; Feldbacher, N; Aliwa, B; Madl, T; Fauler, G; Horvath, A; Stadlbauer, V
Intestinal Permeability in liver cirrhosis
Zeitschrift Gastroenterologie 2023. 2023; 61(05):e192--56. Jahrestagung & 33. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH & ˶Pre˵ Symposium der young ÖGGH; JUN 14 - 17, 2023; Graz, AUSTRIA.
[Poster]
FullText
Haller, R; Fürst, S; Woltsche, J; Gulden, L; Schwarzl, J; Traub, J; Horvath, A; Stadlbauer, V
Evidence of a clinically relevant relationship between intestinal permeability and microbiome composition in cirrhosis.
Doctoral Day 2023; FEB 9, 2023; GRAZ, AUSTRIA. 2023.
[Poster]
Horvath, A; Feldbacher, N; Buchegger, K; Stadlbauer, V
Synbiotic therapy of gastrointestinal symptoms during Covid-19 infection: A randomized, double-blind, placebo controlled, telemedicine study (SynCov Study)
Zeitschrift für Gastroenterologie 2023; 61(05): 191 - 191; DOI: 10.1055/s-0043-1769039. 2023; -56. ÖGGH Jahrestagung & 33. Fortbildungskurs & Pre-Symposium Young ÖGGH; JUN 14 – 17, 2023; Graz, AUSTRIA.
[Poster]
Horvath, A; Feldbacher, N; Buchegger, K; Stadlbauer, V
CHANGES IN THE MICROBIOME AND THE EFFECTS OF A SYNBIOTIC INTERVENTION IN HOME-QUARANTINED PATIENTS WITH MILD SARS-COV-2 INFECTION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, TELEMEDICINE STUDY (SYNCOV STUDY).
United European Gastroenterology Journal 2023; 11 (Supplement 8). 2023; -31st United European Gastroenterology Week, UEGW 2023; OCT 14-17, 2023; Copenhagen, Denmark.
[Poster]
Horvath, A; Habisch, H; Prietl, B; Pfeifer, V; Balazs, I; Kovacs, G; Foris, V; John, N; Kleinschek, D; Feldbacher, N; Buchegger, K; Grønbæk, H; Møller, HJ; Madl, T; Stadlbauer, V
MODULATION OF THE GUT-LUNG AXIS AFTER SEVERE COVID-19 INFECTION THROUGH PROBIOTICS: A PILOT STUDY.
World of Microbiome; OCT 25-28, 2023; Sofia, Bulgaria. 2023.
[Poster]
Horvath, A; Polyak, A; Habisch, H; Balazs, I; Feldbacher, N; Kofler, S; Buchegger, K; Madl, T; Stadlbauer, V
Severe COVID-19 infection causes long-term alterations of the gut-liver axis
Z Gastroenterol 2023; 61(05): e190-e191
DOI: 10.1055/s-0043-1769037. 2023; -56. ÖGGH Jahrestagung & 33. Fortbildungskurs & Pre-Symposium Young ÖGGH; JUN 14-17, 2023; Graz, AUSTRIA.
[Poster]
Horvath, A; Polyak, A; Habisch, H; Balazs, I; Feldbacher, N; Kofler, S; Buchegger, K; Madl, T; Stadlbauer, V
Effects of a multispecies probiotic intake on the recovery of patients with post-acute COVID-19 symptoms; a randomized, double-blind, placebo-controlled pilot trial
Z Gastroenterol 2023; 61(05): e191
DOI: 10.1055/s-0043-1769038. 2023; -56. ÖGGH Jahrestagung & 33. Fortbildungskurs & Pre-Symposium Young ÖGGH; JUN 14-17, 2023; Graz, AUSTRIA.
[Poster]
Horvath, A; Polyak, A; Prietl, B; Pfeifer, V; Habisch, H; Balazs, I; Feldbacher, N; Kofler, S; Buchegger, K; Madl, T; Stadlbauer, V
SEVERE COVID-19 INFECTION CAUSES LONG-TERM ALTERATIONS OF THE GUT-LIVER AXIS.
United European Gastroenterology Journal 2023; 11 (Supplement 8). 2023; -31st United European Gastroenterology Week, UEGW 2023; OCT 14-17, 2023; Copenhagen, Denmark.
[Poster]
Lind, T; Frece, N; Horvath, A; Wurzer, H; Berghold, A; Stadlbauer-Köllner, V
Association between respiratory and gastrointestinal manifestations in COVID-19.
Abstracts. 2023; -56. ÖGGH Jahrestagung & 33. Fortbildungskurs & Pre-Symposium Young ÖGGH; JUN 14-17, 2023; Graz, Austria.
[Poster]
FullText
Morina, E; Stadlbauer, V
Covid-Impfung bei Lebertransplantation
Z Gastroenterol 2023; 61(05): e199. 2023; -56. Jahrestagung & 33. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH & ˶Pre˵ Symposium der young ÖGGH; JUN 14-17, 2023; Graz.
[Poster]
Pacher, C; Horvath, A; Balasz, I; Zukauskaite, K; Feldbacher, N; Haller, R; Hazia, O; Stadlbauer, V
Impact of microplastics on the human gut – A series of bioreactor experiments
2nd Vienna Summit on Microplastics & Health; Dez 1, 2023; Vienna, AUSTRIA. 2023.
[Poster]
FullText
Stadlbauer, V
Darm-Leber-Achse
PRAEVENIRE Gesundheitstagen; May 23, 2023; Seitenstetten. 2023.
[Keynote lecture]
Stadlbauer, V
Dekompensierte Leberzirrhose: Bili steigt - was tun?
Wiener Intensivmedizinische Tage; FEB 14-16, 2023; Wien. 2023.
[Oral Communication]
Stadlbauer, V
Malnutrition andsarcopenia in liver cirrhosis
Meet the Global Expert: Train the Trainer; OCT 26-27, 2023; Frankfurt. 2023.
[Oral Communication]
Stadlbauer, V
Diabetes – Adipositas - Mikrobiom
AKE Jour fixe online; MAR 6, 2023; Wien. 2023.
[Oral Communication]
Stadlbauer, V
Neues Rund um das Mikrobiom
Grazer Fortbildungstage; OKT 14, 2023; 2023.
[Oral Communication]
FullText
Stadlbauer, V
Mikrobiom - die große Unbekannte
ÖAG Jahrestagung; OKT 13, 2023; 2023.
[Oral Communication]
FullText
Stadlbauer, V
HP richtig erkennen: Herausforderungen bei der Diagnose und Chancen für eine erfolgreiche Therapie
ÖGGH 56. Jahrestagung
& 33. Fortbildungskurs & „Pre“ Symposium; JUN 14-17, 2023; Graz. 2023.
[Oral Communication]
Stadlbauer, V
Aszites
ÖGGH 56. Jahrestagung
& 33. Fortbildungskurs & „Pre“ Symposium; JUN 14-17, 2023; Graz. 2023.
[Oral Communication]
Stadlbauer, V
Was sollen Zahnärzt*innen über das Darm-mikrobiom wissen?
Gemeinschaftstagung, ÖGZMK Steiermark; APR 15, 2023; Graz. 2023.
[Oral Communication]
Stadlbauer, V
Leber- und Darmprobleme bei CF
CF-austria Tag; APR 15, 2023; Graz. 2023.
[Oral Communication]
Stadlbauer, V
The use of probiotics in Infections
ItProm; NOV 11, 2023; 2023.
[Keynote lecture]
Stadlbauer, V
The Gut-liver-muscle Axis
Merz Stand-alone Symposium “From gut to brain – new trends in liver cirrhosis”; JUN 21, 2023; 2023.
[Oral Communication]
Stadlbauer, V
Das Darm-Mikrobiom – ein therapeutisches Ziel?“
PRAEVENIRE Gesundheitstagen; MAY 24, 2023; Seitenstetten. 2023.
[Keynote lecture]
Stadlbauer, V
Virushepatitiden
Fachtagung sexuelle Gesundheit 9. Mai 2023; May 9, 2023; Graz. 2023.
[Oral Communication]
Stadlbauer, V
„Leaky Gut“ – was ist das?
40. Ernährungskongresses der Diätologen Österreich; MAR 23-24, 2023; Wien. 2023.
[Oral Communication]
Stadlbauer, V
Darmtherapie und Diagnose
ÖÄK Diplomlehrgang für Kurmedizin; MAR 23-24, 2023; Bad Hofgastein. 2023.
[Oral Communication]
Stadlbauer, V
Sinnhaftigkeit von indikationsspezifischen Probiotika bei Inflammationsgeschehen
19 Jahrestagung der ÖPROM; DEZ 2, 2023; 2023.
[Oral Communication]
Stadlbauer, V
Fettleber
Interne Fortbildung KH Eisenstadt; JUN 21, 2023; 2023.
[Oral Communication]
FullText
Stadlbauer, V
Welche Krankheiten sind mit Probiotika (adjuvant) behandelbar
Fortbildungsveranstaltung Med. Therapieansätze bei GI-Erkrankungen; MAY 15, 2023; 2023.
[Oral Communication]
FullText
Stadlbauer, V
Probiotics in Cirrhosis and Diabesity
Proflora Zen Scientific Conference; JUL 15, 2023; 2023.
[Keynote lecture]
Stadlbauer, V
Microplastic and the Microbiome
Microplastic Workshop PlasticsEurope; May 8-9, 2023; Amsterdam. 2023.
[Oral Communication]
Stadlbauer, V
Darmtherapie und Diagnose
ÖÄK Diplomlehrgang für Kurmedizin; APR 15, 2023; Bad Hofgastein. 2023.
[Oral Communication]
Stadlbauer, V
Diabetes – Adipositas - Mikrobiom
Deutsche Gesellschaft für probiotische Medizin; FEB 17-18, 2023; Berlin. 2023.
[Oral Communication]
Stadlbauer, V.
Modulation of gut microbiota in chronic liver disease
Congress H. Pylori 40 years; JUN 10-1, 2023; Bozen. 2023.
[Oral Communication]
Stadlbauer, V.
Microbiome transplantation as treatment for metabolic diseases
Symposium “Time for the liver – chronobiology, aging and current matters in hepatology”; JAN 25-26, 2023; Bochum. 2023.
[Oral Communication]
Woltsche, JN; Pacher, C; Haller, R; Feldbacher, N; Traub, J; Horvath, A; Stadlbauer, V
Urinary microbiome in patients with liver cirrhosis.
Zeitschrift für Gastroenterologie. 2023; 61(05):-ÖGGH Jahrestagung; JUN 16-17, 2023; Graz, Austria.
[Poster]
FullText
Zukauskaite, K; Horvath, A; Gricius, Z; Dulskas, A; Bausys, R; Sabaliauskaite, R; Jarmalaite, S; Stadlbauer, V; Bausys, A
Preoperative Mechanical Bowel Preparation Impact on the Intestinal Microbiome in Patients Undergoing Left-Sided Colorectal Cancer Surgery
Doctoral Day; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Poster]
Zukauskaite, K; Pacher, C; Kofler, S; Balazs, I; Horvath, A; Stadlbauer, V
Establishment of an in vitro microbiome model of the human gut microbiome using the DASbox mini bioreactor system
Zeitschrift für Gastroenterologie. 2023; 61(05):192-193.-Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 14-17, 2023; Graz, AUSTRIA.
[Poster]
FullText
Zukauskaite, K; Pacher, C; Kofler, S; Balazs, I; Horvath, A; Stadlbauer, V
OPTIMIZING CONDITIONS FOR IN VITRO MODELING OF THE HUMAN GUT MICROBIOME TO STUDY INTESTINAL HEALTH AND DISEASE.
World of Microbiome; OCT 25-28, 2023; Sofia, Bulgaria. 2023.
[Poster]
Zukauskaite, K; Pacher, C; Kofler, S; Balazs, I; Horvath, A; Stadlbauer, V
Optimizing conditions for in vitro modeling of the human gut microbiome to study intestinal health and disease
United European Gastroenterology Journal. 2023; 11(S8):511-512.-The 31st United European Gastroenterology Week; OCT 14-17, 2023; Copenhagen, DENMARK.
[Poster]
FullText
Zukauskaite, K; Pacher, C; Kofler, S; Balazs, I; Horvath, A; Stadlbauer, V;
Development of an In Vitro Microbiome Model of the Human Gut Utilizing the DASbox® Mini Bioreactor System
Berchtesgaden Microbiome Science Days; SEP 7-9, 2023; Berchtesgaden, GERMANY. 2023.
[Poster]
Aliwa, B; Feldbacher, N; Horvath, A; Traub, J; Madl, T; Fauler, G; Stadlbauer, V
Altered gut microbiome, metabolome and bile acid composition in sarcopenia in liver cirrhosis
J HEPATOL. Abstracts of The International Liver Congress 2022. 2022; 77: S68-S68.-International Liver Congress; JUN 22-26, 2022; London, ENGLAND.
[Oral Communication]
Web of Science
Balazs, I; Racedo, S; Fickert, P; Stadlbauer, V
Comparative analysis between different types of autoantibodies and their effects on NETs formation
Zeitschrift für Gastroenterologie. 2022; 60(08):e688-e688.-55. Jahrestagung & 32. Fortbildungskurs der ÖGGH Hybridveranstaltung; SEP 7-9, 2022; Vienna, AUSTRIA.
[Poster]
FullText
Castellani, C; Obermüller, B; Kienesberger, B; Singer, G; Klymiuk, I; Horvath, A; Stadlbauer, V; Till, H; Mayrhofer, S; Grabherr, R; Heinl, S
Produktion und antibakterielle Aktivität von Reuterin und Effekt auf das murine fäkale Mikrobiom und Volatile Organic Compound Profil.
Eur Surg. 2022; 54(Supp 1):-63. Österreichischer Chirurgenkongress; JUN 15-17, 2022; Graz, AUSTRIA.
[Oral Communication]
FullText
Castellani, C; Obermüller, B; Kienesberger, B; Singer, G; Klymiuk, I; Horvath, A; Stadlbauer, V; Zügner, E; Magnes, C; Trajanoski, S; Lopez-Garcia, P; Miekisch, W; Fuchs, P; Till, H
Verhalten einer Co-Kultur 10 probiotischer Stämme und Wirksamkeit des postbiotischen Kulturüberstandes in vitro und in vivo.
Eur Surg. 2022; 54(Supp 1):-63. Österreichischer Chirurgenkongress; JUN 15-17, 2022; Graz, AUSTRIA.
[Oral Communication]
FullText
Castellani, C; Obermüller, B; Kienesberger, B; Singer, G; Peterbauer, C; Grabherr, R; Mayrhofer, S; Klymiuk, I; Horvath, A; Stadlbauer, V; Russmayer, H; Miekisch, W; Fuchs, P; Till, H; Heinl S
Production, Storage Stability, and Susceptibility Testing of Reuterin and Its Impact on the Murine Fecal Microbiome and Volatile Organic Compound Profile
139. Deutscher Chirurgenkongress; APR 6-8, 2022; Leipzig, GERMANY. 2022.
[Oral Communication]
Haller, R; Aliwa, B; Horvath, A; Stadlbauer, V
Intestinal hyperpermeability in cirrhosis is predictive for survival and associated with distinct microbiome changes
J HEPATOL. Abstracts of The International Liver Congress 2022. 2022; 77: S179-S179.-International Liver Congress; JUN 22-26, 2022; London, ENGLAND.
[Poster]
Web of Science
Haller, R; Horvath, A; Stadlbauer, V
Differences in microbiome composition in cirrhotic patients with high and low zonulin levels
Doctoral Day; FEB 10, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Haller, R; Horvath, A; Stadlbauer, V
Differences in microbiome composition in cirrhotic patients with increased intestinal permeability.
Zeitschrift für Gastroenterologie 2022;60(08): e686-e687
. 2022; -Jahrestagung & 32. Fortbildungskurs der ÖGGH Hybridveranstaltung; SEP 7-9, 2022; Vienna, AUSTRIA.
[Poster]
FullText
Hartl, L; Tatscher, E; Weiß, M; Balcar, L; Strassl, R; Jachs, M; Mandorfer, M; Soliman, T; Stadlbauer, V; Schemmer, P; Berlakovich, G; Tilg, H; Schneeberger, S; Trauner, M; Fickert, P; Reiberger, T; Graziadei, I
Impact of COVID-19 on liver transplantation in Austria.
Abstracts 55. Jahrestagung & 32. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung). 2022; -55. Jahrestagung & 32. Fortbildungskurs der ÖGGH Hybridveranstaltung; SEPT 7-9, 2022; Vienna, AUSTRIA.
[Poster]
Horvath, A; Balazs, I; Feldbacher, N; Kofler, S; Haller, R; Aliwa, B; Pacher, C; Stadlbauer, V
Nachhaltigkeit in der Forschung während und nach der COVID-19 Pandemie
Zeitschrift für Gastroenterologie. 2022; 60(08):e689-e690.-55. Jahrestagung & 32. Fortbildungskurs der ÖGGH Hybridveranstaltung; SEP 7-9, 2022; Vienna, AUSTRIA.
[Poster]
FullText
Kienesberger, B; Obermüller, B; Singer, G; Grabher, R; Stadlbauer, V; Horvath, A; Miekisch, W; Fuchs, P; Klymiuk, I; Till, H; Castellani, C
(S)-Reutericyclin: Susceptibility Testing and in vivo Effect on Murine Fecal
Microbiome and Volatile Organic Compounds
https://pubmed.ncbi.nlm.nih.gov/34203988/. 2022; -Doc Day 2022 - Public Presentations for Doc School and PhD Students; FEB 10, 2022; Graz, AUSTRIA.
[Onlinepräsentation]
FullText
Kienesberger, B; Obermüller, B; Singer, G; Mittl, B; Grabherr, R; Mayrhofer, S; Heinl, S; Stadlbauer, V; Horvath, A; Miekisch, W; Fuchs, P; Klymiuk, I; Till, H; Castellani, C
(S)-Reutericyclin: Susceptibility Testing and In Vivo Effect on Murine Fecal Microbiome and Volatile Organic Compounds
139. Deutscher Chirurgenkongress; APR 6-8, 2022; Leipzig, GERMANY. 2022.
[Oral Communication]
Madl, T; Kerbl-Knapp, J; Rainer, F; Douschan, P; Stadlbauer, V; Avian, A; Marsche, G; Claria, J; Stauber, RE
A novel metabolomics-based prognostic model shows superior diagnostic accuracy than MELD in chronic liver failure
J HEPATOL. 2022; 77: S346-S346.-EASL Annual Meeting; JUN 22-26, 2022; London, UK.
[Poster]
Web of Science
Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Muller, A; Jacan, A; Schauer, M; Jacan, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Pieber, TR; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
Intermittent fasting is safe and improves metabolic parameters in people with insulin treated type 2 diabetes: a randomised controlled trial
DIABETOLOGIA. Abstracts 58th Annual Meeting of the EASD. 2022; 65(SUPPL 1):S276-S276.-58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 19-23, 2022; Stockholm, SWEDEN.
[Oral Communication]
Web of Science
Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Muller, A; Jacan, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Pieber, TR; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
Intermittent fasting is safe and improves metabolic parameters in people with insulin-treated type 2 diabetes mellitus a randomized controlled trial
WIEN KLIN WOCHENSCHR. Abstracts der 50. Jahrestagung der Österreichischen Diabetes Gesellschaft. 2022; 134(SUPPL 4):252-253.-50. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2022; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Pacher, C; Horvath, A; Balasz, I; Buchegger, K; Feldbacher, N; Kofler, S; Stadlbauer, V
microONE Project 4:
Microplastic and the Microbiome
First Vienna Summit on Microplastics and Health; 28.09.2022; Vienna, AUSTRIA. 2022.
[Poster]
FullText
Stadlbauer, V
gastrointestinale Blutungen
FOMF Jungärzte; MAR 3, 2022; Wien. 2022.
[Oral Communication]
Stadlbauer, V
Sarkopenie und die Leber - eine Wechselbeziehung
Symposium Labormedizin ÖGLMKC; May 5, 2022; Seggauberg. 2022.
[Oral Communication]
Stadlbauer, V
Darm-Lungen-Achse
18. Internationalen Symposium der OePROM; DEC 3, 2022; Wien, Austria. 2022.
[Oral Communication]
Stadlbauer, V
Wichtige Lebererkrankungen
Innere Medizin Update Refresher Wien, FOMF; NOV 30, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V
Mikrobiom: Liver-Gut-Interaction
Zukunftssymposium Hepatologie 2030; NOV 18-19, 2022; Essen, Germany. 2022.
[Oral Communication]
Stadlbauer, V
Unser Mikrobiom: Neue Erkenntnisse zur Rolle in Gesundheit und Krankheit
Immunologie im Herbst, Urania; NOV 15, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V
Standarf of Care - Gastro & Leber
CF-Kompakt – Fortbildung für JungmedizinerInnen; NOV 4, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V
Welche Krankheiten sind mit Probiotika (adjuvant) behandelbar
Dresdener Fachtagung für Ernährungsmedizin; SEP 30, 2022; Dresden. 2022.
[Oral Communication]
Stadlbauer, V
Die Rolle des Mikrobioms bei Lebererkrankungen
Fachakademie für Ärzte; JUN 17, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V
Verdauungsbeschwerden
STAFAM Akademie für Allegmeinmedizin Webinar; MAY 5, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V
Probiotic therapy in liver cirrhosis
1° Congresso internazionale ItPROM
Il mondo dei Probiotici
Prevenzione e terapia; NOV 25-26, 2022; Rom, Italien. 2022.
[Oral Communication]
Stadlbauer, V
News from the microbiome How drugs modulate bugs, how bugs modulate drugs
Institutsseminar Nuklearmedizin Meduni Wien; May 12, 2022; Wien. 2022.
[Oral Communication]
Stadlbauer, V
Long Covid....aus gastroenterologischer Sicht
32. Grazer Fortbildungstage; OCT 13, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V
Die Leber auf der Intensivstation
Blockkurs Facharztausbildung Anästhesie; OCT 10, 2022; Salzburg. 2022.
[Oral Communication]
Stadlbauer, V
Drug-microbiome interaction
5th International CBmed Biomarker Conference ; SEP 27, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V
Hereditäre Stoffwechselerkrankungen am Beispiel der akuten hepatischen Porphyrie
55. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; Sep 7-9, 2022; Wien. 2022.
[Oral Communication]
Stadlbauer, V
Differenzialdiagnose der Hepatosplenomegalie
55. JAHRESTAGUNG der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; SEP 7-9, 2022; Wien. 2022.
[Oral Communication]
Stadlbauer, V
Akutes Leberversagen
55. JAHRESTAGUNG der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; SEP 7-9, 2022; Wien. 2022.
[Oral Communication]
Stadlbauer, V
Medikamente & Mikrobiom – Relevanz in der Intensivmedizin
Intensiver Sommer 2022; JUL 6, 2022; 2022.
[Oral Communication]
Stadlbauer, V
Prä- und Probiotika
Ernährungsmedizin; JUL 2, 2022; Wien. 2022.
[Oral Communication]
Stadlbauer, V
Darmtherapie & Diagnose
ÖÄK Diplomlehrgang für Kurmedizin; Jun 11, 2022; Bad Hofgastein. 2022.
[Oral Communication]
Stadlbauer, V
Essenzen aus dem Gipfelgespräch Darmgesundheit 2023
7. PRAEVENIRE Gesundheitstage ; May 18, 2022; 2022.
[Keynote lecture]
Stadlbauer, V
Prä- und Probiotika
5. ÖÄK-Diplomlehrgang Ernährungsmedizin; JUN 11, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V
The gut-liver-muscle axis in cirrhosis
Merz International Symposium; APR 8, 2022; Wiesbaden. 2022.
[Oral Communication]
Stadlbauer, V
Nebenwirkung von Immuntherapie.....aus gastroenterologischer Sicht
Jahrestagung ÖHGO; APR 8, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V
Mikroplastik und das Mikrobiom
DEPROM; FEB 25-26, 2022; Berlin. 2022.
[Oral Communication]
Stadlbauer, V
Bauchschmerzen
FOMF Jungärzte; MAR 3, 2022; Wien. 2022.
[Oral Communication]
Stadlbauer, V
Differentialdiagnose der Hepatosplenomegalie
; APR 29, 2022; 2022.
[Oral Communication]
Stadlbauer, V
Prä- und Probiotika
Ernährungsmedizin ; APR 23, 2022; Wien. 2022.
[Oral Communication]
Stadlbauer, V; Tatscher, E
OTC in der Gastroenterologie
32. Grazer Fortbildungstage; OCT 13, 2022; Graz. 2022.
[Oral Communication]
Stadlbauer, V; Tatscher, E
Sinnhaftigkeit von OTC-Präparaten in der Gastroenterologie
32. Grazer Fortbildungstage der Ärztekammer Steiermark; OCT 10-15, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Steidl, K; Gröchenig, H; Siebert, F; Stadlbauer, V
Seltene Ursache eines akuten Leber- und Nierenversagen mit disseminierter intravasaler Gerinnung
Z Gastroenterol 2022; 60(08): e687. 2022; -55. Jahrestagung & 32. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung). 2022; SEP 7-9; Wien.
[Poster]
Stelzer, M; Balazs, I; Horvath, A; Feldbacher, N; Traub, J; Stadlbauer, V
Role of neutrophil extracellular trap formation in liver cirrhosis and sarcopenia
Zeitschrift für Gastroenterologie. 2022; 60(08):e702-e703.-55. Jahrestagung & 32. Fortbildungskurs der ÖGGH Hybridveranstaltung; SEP 7-9, 2022; Vienna, AUSTRIA.
[Poster]
FullText
Wagner, T; Stadlbauer-Köhler, V; Stöger, K; Schorna, K; Zink, M
Criminal and civil responsibility of the donor in a case of transmission of malaria by a blood transfusion in a non-endemic country.
Transfusion Medicine and Hemotherapy. 2022; 49(S1):16-17.-DGTI - Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie; Sep 21-23, 2022; Mannheim, Deutschland. (ISBN: 1660-3796 )
[Oral Communication]
FullText
Zukauskaite, K; Horvath, A; Gricius, Z; Dulskas, A; Bausys, R; Sabaliauskaite, R; Jarmalaite, S; Stadlbauer, V; Bausys, A
Bowel Preparation Impact on the Intestinal Microbiome in patients undergoing left-sided colorectal cancer surgery: results from Pilot randomized control trial comparing Oral Preparation vs Enema
Z Gastroenterol 2022; 60(08): e673-e674. 2022; -55. Jahrestagung & 32. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung). 2022; SEP 7-9; Wien.
[Poster]
FullText
Agarwal, B; Saliba, F; Tomescu, DR; Canizares, RB; Martin, D; Stadlbauer, V; Wright, G; Sheikh, M; Morgan, C; Andreola, F; Oettl, K; Waterstradt, K; Bode-Boger, SM; Kumar, R; Alabsawy, EI; Samuel, D; Ichai, P; Hernandez-Tejero, M; Aziz, F; Hinz, M; Popescu, M; Catalina, MV; Corrigall, D; Creteur, J; Lheurex, O; Durand, F; Aagaard, NKM; Nf, A; Elsharkawy, A; Serrano, S; Paar, M; Sacleux, SC; Schilcher, G; Koball, S; Tudor, A; Ibanez, L; Minten, J; Domenech, G; Aragones, JJ; Gander, A; Sanchez, M; Mookeerjee, R; Davenport, A; Green, D; Pavesi, M; Stange, J; Davies, N; Arroyo, V; Fernandez, J; Mitzner, S; Jalan, R
A multi-centre, randomized controlled study, to evaluate the safety and performance of the DIALIVE Liver Dialysis Device in patients with Acute on Chronic Liver Failure (ACLF) versus standard of care (SOC)
J HEPATOL. 2021; 75: S194-S196.
[Oral Communication]
Web of Science
Agarwal, B; Saliba, F; Tomescu, DR; Canizares, RB; Martin, D; Stadlbauer, V; Wright, G; Sheikh, M; Morgan, C; Andreola, F; Oettl, L; Alzola, C; Kumar, R; Sacleux, SC; Schilcher, G; Koball, S; Tudor, A; Minten, J; Domenech, G; Aragones, JJ; Oettl, K; Waterstradt, K; Bode-Boger, SM; Ibanez, L; Gander, A; Stange, J; Sanchez, M; Mookerjee, RP; Davenport, A; Davies, N; Pavesi, M; Fernandez, J; Mitzner, S; Arroyo, V; Jalan, R
A MULTI-CENTRE, RANDOMIZED CONTROLLED STUDY, TO EVALUATE THE SAFETY AND PERFORMANCE OF THE DIALIVE LIVER DIALYSIS DEVICE IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE (ACLF) VERSUS STANDARD OF CARE (SOC) (ALIVER CONSORTIUM)
GUT. 2021; 70: A54-A54.
Doi: 10.1136/gutjnl-2021-BASL.84
[Oral Communication]
Web of Science
FullText
FullText_MUG
Aliwa, BO; Horvath, A; Traub, J; Feldbacher, N; Stadlbauer, V;
Gut Microbiome Dysbiosis, Bile acids, and Sarcopenia in Liver Cirrhosis.
Z Gastroenterol 2021; 59(08): e356. 2021; -54. Jahrestagung & 31. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung); SEP 9-11, 2021; Linz, Austria.
[Poster]
Balazs, I; Horvath, A; Leber, B; Feldbacher, N; Fauler, G; Stadlbauer, V
Gut microbiome composition in liver cirrhosis is associated with serum bile acid profile
Zeitschrift für Gastroenterologie. 2021; 59(08):e361-e362.-54. Jahrestagung & 31. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung); SEP 9-11, 2021; Linz, AUSTRIA.
[Poster]
FullText
Balazs, I; Horvath, A; Leber, B; Feldbacher, N; Vermeren, S; Stadlbauer, V
Bile acids mediated neutrophil function impairment in liver cirrhosis
Doctoral Day 2021; FEB 12, 2021; Graz, AUSTRIA. 2021.
[Poster]
Canizares, RB; Saliba, F; Agarwal, B; Tomescu, DR; Martin, D; Stadlbauer, V; Wright, G; Sheikh, M; Morgan, C; Andreola, F; Oettl, K; Waterstradt, K; Kumar, R; Bode-Boeger, SM; Sacleux, SC; Schilcher, G; Koball, S; Tudor, A; Alabsawy, E; Didier, S; Ichai, P; Hernandez-Tejero, M; Aziz, F; Hinz, M; Popescu, M; Catalina, MV; Corrigall, D; Creteur, J; Paar, M; Serrano, S; Aehling, NF; Elsharkawy, A; Aagaard, NKM; Lheureux, O; Durand, F; Minten, J; Domenech, G; Aragones, JJ; Gander, A; Sancez, M; Mookeerjee, R; Davenport, A; Green, D; Pavesi, M; Stange, J; Davies, N; Arroyo, V; Fernandez, J; Mitzner, S; Jalan, R
Pathophysiological basis of resolution of Acute-on-Chronic Liver Failure (ACLF) induced by the novel liver dialysis device, DIALIVE
J HEPATOL. 2021; 75: S209-S210.
[Oral Communication]
Web of Science
Canizares, RB; Saliba, F; Tomescu, D; Agarwal, B; Stadlbauer, V; Wright, G; Sheikh, M; Morgan, C; Andreola, F; Oettl, L; Alzola, C; Kumar, R; Sacleux, SC; Schilcher, G; Green, D; Koball, S; Tudor, A; Minten, J; Domenech, G; Aragones, JJ; Oettl, K; Waterstradt, K; Bode-Boger, S; Catalina, MV; Gander, A; Stange, J; Sanchez, M; Mookerjee, RP; Davenport, A; Davies, N; Pavesi, M; Fernandez, J; Mitzner, S; Arroyo, V; Jalan, R
PATHOPHYSIOLOGICAL BASIS OF RESOLUTION OF ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) INDUCED BY THE NOVEL LIVER DIALYSIS DEVICE, DIALIVE (ALIVER CONSORTIUM)
GUT. 2021; 70: A55-A55.
Doi: 10.1136/gutjnl-2021-BASL.85
[Poster]
Web of Science
FullText
FullText_MUG
Kohlmaier, B; Gunther, N; Benesch, M; Fickert, P; Lackner, H; Lagler, H; Liegl-Atzwanger, B; Stadlbauer, V; Strenger, V; Stroedter, L; Sorantin, E; Till, H; Zenz, W; Hauer, A.
Leberzyste und pulmonale Rundherde - Zystische Echinokokkose und andere Bösartigkeiten.
Abstractband Monatsschrift Kinderheilkunde. 2021; 169, Suppl. 2: S60--59. Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde; SEP 30 - OCT 2, 2021; Salzburg, AUSTRIA.
[Poster]
Lind, T; Frece, N; Horvath, A; Wurzer, H; Berghold, A; Stadlbauer, V;
Covid-19 and gastrointestinal manifestations: A retrospective cohort study.
Z Gastroenterol 2021; 59(08). 2021;. 2021; -54. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; SEP 9-11, 2021; Linz, AUSTRIA.
[Poster]
Stadlbauer, V
Interaktion Mikrobiom-Medikamente-Immunsystem
Symposium Stift Göttweig; AUG 28, 2021; Göttweig. 2021.
[Oral Communication]
Stadlbauer, V
Medikamente und Mikrobiom
Medwoche Baden-Baden; NOV 1, 2021; Baden-Baden. 2021.
[Oral Communication]
Stadlbauer, V
Das Mikrobiom bei Diabetes, Adipositas und metabolischem Syndrom
Medwoche Baden-Baden; NOV 1, 2021; Baden-Baden. 2021.
[Oral Communication]
Stadlbauer, V
Porphyrien: Bauchschmerzen für Fortgeschrittene
54. Jahrestagung der ÖGGH; SEP 9-11, 2021; Linz. 2021.
[Oral Communication]
Stadlbauer, V
Der Einfluss von Medikamenten, Stress und gesunder Ernährung auf das Mikrobiom
ÄGHE Fortbildungstagung Marienkron; JUN 19, 2021; Marienkron. 2021.
[Onlinepräsentation]
Stadlbauer, V
Häufige Lebererkrankungen – Diagnostik und Therapie
Forum für medizinische Fortbildung; JUN 17, 2021; Wien. 2021.
[Onlinepräsentation]
Stadlbauer, V
Gastrointestinale Blutungen
Forum für medizinische Fortbildung ; MAR 3, 2021; Wien. 2021.
[Onlinepräsentation]
Stadlbauer, V
Wer verdient eine Lebertransplantation?
54. Jahrestagung der ÖGGH; SEP 9-11, 2021; Linz. 2021.
[Oral Communication]
Stadlbauer, V
Abklärung unklarer Hepatosplenomegalie
Jahrestagung der ÖGIM; SEP 22-24, 2021; Salzburg. 2021.
[Oral Communication]
Stadlbauer, V
Mikrobiom-modulation durch Probiotika
Jahrestagung der ÖGIM; SEP 22-24, 2021; Salzburg. 2021.
[Oral Communication]
Stadlbauer, V.
Lebertransplantation
Interne Fortbildung BHB Graz; MAY 20, 2021; Graz. 2021.
[Oral Communication]
Stadlbauer, V.
Das Mikrobiom bei Lebererkrankungen
Fachakademie für Ärzte; JUN 18, 2021; Graz. 2021.
[Oral Communication]
Stadlbauer, V.
Die Darm-Leber-Muskelachse
DeProm 2021; FEB 20, 2021; Wandlitz. 2021.
[Onlinepräsentation]
Stadlbauer, V.
Optimizing metabolic health: A role for probiotics?
Probiota Europe 2021; FEB 10, 2021; West Sussex, UK. 2021.
[Onlinepräsentation]
Stadlbauer V
Prä- und Probiotika
ÖAK Diplom Ernährungsmedizin Wien; JAN 30, 2021; Wien. 2021.
[Onlinepräsentation]
Stadlbauer V
Prä- und Probiotika
ÖÄK Diplom Ernährungsmedizin Wien; JUN 19, 2021; Wien. 2021.
[Onlinepräsentation]
Stadlbauer V
Abklärung abdomineller Schmerz
Forum für medizinische Fortbildung; MAR 3, 2021; Wien. 2021.
[Onlinepräsentation]
Stadlbauer, V.
Diabetes und Mikrobiom
Fortbildung Apothekerkammer Wien und Kärnten; JAN 28, 2021; 2021.
[Onlinepräsentation]
Stadlbauer, V; Jud, P; Hackl, G; Reisinger, A; Eller, P; Horvath, A;
Impact of COVID-19 on rare diseases: Report of three cases of acute hepatic porphyria affected by the pandemic
Z Gastroenterol 2021; 59(08). 2021;. 2021; -54. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; SEP 9-11, 2021; Linz, AUSTRIA.
[Poster]
Stadlbauer, V; Tatscher, E
OTC in der Gastroenterologie
31 Fortbildungstage der Ärztekammer Steiermark; KCT 10, 2021; Graz. 2021.
[Oral Communication]
Stadlbauer, V; Zink, M
Organspendebedarf in Österreich
Jahrestagung Austrotransplant; OCT 21-22, 2021; Spielberg. 2021.
[Oral Communication]
Stadlbauer, V; Zink, M
ORGAN DONATION DEMAND IN AUSTRIA
TRANSPL INT. 2021; 34: 24-24.
[Oral Communication]
Web of Science
Stehrer, R; Rugani, P; Jakse, N; Horvath, A; Stadlbauer, V
Zahnärztliche Herdsanierung vor Lebertransplantation – eine retrospektive Studie
45. Österreichischer Zahnärztekongress 2021; SEP 16-18, 2021; Vienna, AUSTRIA. 2021.
[Poster]
Stehrer, R; Rugani, P; Stadlbauer-Köllner, V
Zahnärztliche Herdsanierung vor Lebertransplantation - eine retrospektive Studie
POSTER Hepatologie
Z Gastroenterol 2021; 59(08): e360
DOI: 10.1055/s-0041-1734314. 2021; -54. ÖGGH Jahrestagung ; SEP 10-11, 2021; Linz, AUSTRIA.
[Poster]
FullText
Altekruse, A; Kovacs, G; Sassmann, T; Foris, V; Avian, A; Stadlbauer, V; Stauber, R; Olschewski, H; Douschan, P
Pulmonary exercise hemodynamics in patients with liver cirrhosis - a stress echocardiography study.
EUR RESPIR J. 2020; 56:
Doi: 10.1183/13993003.congress-2020.1513
[Poster]
Web of Science
FullText
FullText_MUG
Engertsberger, L; Horvath, A; Komarova, I; Feldbacher, N; Leber, B; Pichler, G; Fink, N; Scarpatetti, M; Schippinger, W; Schmidt, R; Stadlbauer, V
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use.
Zeitschrift für Gastroenterologie. 2020; 58(05):e86-e87.-53. Jahrestagung der ÖGGH; JUN 18-19, 2020; Salzburg, AUSTRIA.
Doi: 10.1055/s-0040-1712280
[Poster]
FullText
FullText_MUG
Fürschuß, L; Rainer, F; Effenberger, M; Niederreiter, M; Portugaller, R; Fickert, P; Stadlbauer, V
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt (TIPS).
Digital ILC 2020 Abstract book. 2020; -The Digital International Liver Congress 2020; AUG 27-29, 2020; London, UK.
[Poster]
Fürschuß, L; Rainer, F; Effenberger, M; Niederreiter, M; Portugaller, RH; Fickert, P; Stadlbauer, V
A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency.
Zeitschrift für Gastroenterologie / German Journal of Gastroenterology 2020. 2020; (58):e102-e102.-53. ÖGGH Jahrestagung 2020; JUN 18-19, 2020; Vienna, AUSTRIA.
[Poster]
Furschuss, L; Rainer, F; Effenberger, M; Niederreiter, M; Portugaller, RH; Fickert, P; Stadlbauer, V
The modified TIPS-Score (MOTS) improves the Assessment of the Mortality Risk after transjugular intrahepatic portosystemic Shunt (TIPS) and thus the Patient Selection.
WIEN KLIN WOCHENSCHR. 2020; 132(SUPPL 2):76-77.London, online.
[Poster]
Web of Science
Horvath, A; Meyer, C; Stadlbauer, V
Where have all the women gone? - The Representation of Women in the medical Specialist Societies of Austria.
WIEN KLIN WOCHENSCHR. 2020; 132(SUPPL 2):75-75.-ÖGGH Jahrestagung; Online, Wien.
[Poster]
Web of Science
Komarova, I; Horvath, A; Leber, B; Feldbacher, N; Vermeren, S; Stadlbauer, V
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis.
Zeitschrift für Gastroenterologie. 2020; 58(05):e92--53. Jahrestagung der ÖGGH; JUN 18-19, 2020; Salzburg, AUSTRIA.
[Poster]
FullText
Komarova, I; Horvath, A; Leber, B; Feldbacher, N; Vermeren, S; Stadlbauer, V
Bile acids modify ROS production, impair chemotaxis and delay apoptosis of neutrophils in vitro.
Journal of Hepatology. 2020; 73: S210--International Liver Congress; AUG 27-29, 2020; London, UK.
[Poster]
FullText
Munda, P; Aigner, E; Ferlitsch, A; Gschwantler, M; Hofer, H; Maieron, A; Peck-Radosavljevic, M; Stadlbauer-Kollner, V; Wagner, M
Diagnosis and Risk Stratification of non-alcoholic Steatohepatitis (NASH) - a Recommendation from Austrian Hepatologists.
WIEN KLIN WOCHENSCHR. 2020; 132(SUPPL 2):78-78.-ÖGGH Jahrestagung; ÖGGH Wien.
[Oral Communication]
Web of Science
Negrean, I; Stadlbauer-Köllner, V; Horvath, A; Feldbacher, N; Posch, A; Streit, A; Stauber, R
Fibroscan® probe selection for lean adults.
Zeitschrift für Gastroenterologie / German Journal of Gastroenterology 2020. 2020; (58):e92-e92.-53. ÖGGH Jahrestagung 2020; JUN 18-19, 2020; Vienna, AUSTRIA.
[Poster]
Stadlbauer, V
The gut-liver axis as therapeutic target in chronic liver diseases.
World of Microbiome; NOV 4-6, 2020; Online, Kenes Group, HQ Switzerland. 2020.
[Oral Communication]
Stadlbauer V
Bauchschmerz: Orchideen.
Bauchschmerz für Fortgeschrittene; Feb 7, 2020; Graz. 2020.
[Oral Communication]
Stadlbauer V
Abklärung erhöhter Leberwerte.
FOMF Allgemeinmedizin Update Refresher; Jan 29, 2020; Graz. 2020.
[Oral Communication]
Stadlbauer V
Gastrointestinale Blutungen.
FOMF Turnusärzte; Feb 20, 2020; Wien. 2020.
[Oral Communication]
Stadlbauer V
Mikrobiom und Immunsystem.
Jahrestagung Adler Pharma; Sep 27, 2020; Zell am See. 2020.
[Oral Communication]
Stadlbauer V
Wichtige Lebererkrankungen: Diagnose und Therapie.
FOMF Innere Medizin Update Refresher; MAY 17, 2020; online. 2020.
[Oral Communication]
Stadlbauer V
Abklärung erhöhter Leberwerte.
FOMF Allgemeinmedizin Update Refrescher; MAY 17, 2020; online. 2020.
[Oral Communication]
Stadlbauer V
CF – Comorbiditäten - Leber und andere gastroenterologische Probleme.
Interdisziplinäre Fortbildung für CF Teams 2020; NOV 6, 2020; online. 2020.
[Oral Communication]
Stadlbauer V
Rückblick BMSD 2019.
6. deutsche Mikrobiomtage; FEB 21-22, 2020; Berlin. 2020.
[Oral Communication]
Stadlbauer V
Kann das Mikrobiom bei der Gewichtsabnahme helfen?
6. deutsche Mikrobiomtage; FEB 21-22, 2020; Berlin. 2020.
[Oral Communication]
Stadlbauer V
Covid-19 in der gastroenterologie und hepatologie.
Intensiver Sommer 2020; JUL 3, 2020; online. 2020.
[Oral Communication]
Stadlbauer V
Stellenwert der Mikrobiommodulation bei Diabetes und Adipositas.
6. Internationalen Symposiums der österreichischen Gesellschaft für probiotische Medizin; NOV 21, 2020; online. 2020.
[Oral Communication]
Stadlbauer V
Covid-19 in gastroenterology and hepatology.
Structural Biology Meets Clinic; Dec 2, 2020; online. 2020.
[Oral Communication]
Stadlbauer V
Das Mikrobiom bei chronischen Lebererkrankungen.
1. online Fachakademie; MA 28, 2020; online. 2020.
[Oral Communication]
Stadlbauer V
Porphyria care at the Medical University of Graz, Austria.
Virtual AHP Workshop; Nov 25, 2020; online. 2020.
[Oral Communication]
Stadlbauer V
Lebertransplantation.
Fortbildung BHB St Veit; Sep 21, 2020; St Veit an der Glen. 2020.
[Oral Communication]
Stadlbauer V
Abklärung Abdomineller Schmerz.
FOMF Turnusärzte; Feb 20, 2020; Wien. 2020.
[Oral Communication]
Stadlbauer, V; Komarova, I; Klymiuk, I; Durdevic, M; Reisinger, A; Blesl, A; Rainer, F; Horvath, A
Disease severity and proton pump inhibitor use impacts strongest on faecal microbiome composition in cirrhosis.
Journal of Hepatology. 2020; 73: S235-S236.-International Liver Congress; AUG 27-29, 2020; London, UK.
[Poster]
FullText
Steinwender, M; Leber, B; Feldbacher, N; Komarova, I; Rainer, F; Blesl, A; Horvath, A; Stadlbauer-Köllner, V
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie.
Zeitschrift für Gastroenterologie . 2020; 58(05):e88--53. Jahrestagung der ÖGGH; JUN 18-19, 2020; Salzburg, AUSTRIA.
[Poster]
FullText
Traub, J; Bergheim, I; Eibisberger, M; Stadlbauer, V
Sarcopenia and liver cirrhosis-Comparison of the European Working group on Sarcopenia criteria 2010 and 2019
Digital ILC 2020 Abstract book. 2020; -The Digital International Liver Congress 2020; AUG 27-29, 2020; London, UK.
[Poster]
Traub, J;, Bergheim, I; Horvath, A; Stadlbauer, V
Validation of malnutrition screening tools in liver cirrhosis.
Clinical Nutrition ESPEN 2020. 2020; -ESPEN Kongress; SEP 19-21, 2020; Lyon, FRANCE.
[Poster]
Traub, J; Eibisberger, M; Bergheim, I; Stadlbauer, V
Sarcopenia and liver cirrhosis- Comparison of the European Working group on Sarcopenia criteria 2010 and 2019.
Zeitschrift für Gastroenterologie / German Journal of Gastroenterology 2020. 2020; (58):e101-e101.-53. ÖGGH Jahrestagung 2020; JUN 18-19, 2020; Vienna, AUSTRIA.
[Poster]
Horvath, A; Durdevic, M; Leber, B; di Vora, K; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, R; Fickert, P; Stiegler, P; Stadlbauer, V
Changes in the intestinal microbiome during probiotic intervention in cirrhosis
J HEPATOL. 2019; 70: E648-E648.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA.
Doi: 10.1016/S0618-8278(19)31290-3
[Poster]
Web of Science
FullText
FullText_MUG
Horvath, A; Durdevic, M; Leber, B; di Vora, KG; Rainer, F; Douschan, P; Krones, E; Spindelböck, W; Baumann-Durchschein, F; Zollner, G; Stauber, R; Fickert, P; Stiegler, P; Stadlbauer, V:
The modulation of the gut microbiome during a multispecies probiotic intervention in compensated cirrhosis
Z Gastroenterol 2019; 57(05): e158
DOI: 10.1055/s-0039-1691924. 2019; -Jahrestagung der ÖGGH; JUN 13-15, 2019; Innsbruck, Austria.
[Poster]
Horvath, A; Leber, B; Feldbacher, N; Tripolt, N; Rainer, F; Blesl, A; Trieb, M; Marsche, G; Sourij, H; Stadlbauer, V
A randomized, double-blind, placebo-controlled pilot study on the effects of a multispecies synbiotic in diabesity
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S470-S470.-47. Jahrestagung der ÖDG; NOV 21-23, 2019;
[Poster]
Web of Science
Horvath, A; Stadlbauer, V
Mikrobiom und Alterungsprozesse
JAHRESKONGRESS 2019
NETZWERK ALTERSMEDIZIN; OKT 10-12, 2019; Graz, Austria. 2019.
[Oral Communication]
Horvath, A; Stadlbauer-Köllner, V
Drug-Microbiome-Interaction: General considerations and examples from human studies
Berchtesgaden Microbiome Science Days; SEP 19-21, 2019; Berchtesgaden, Germany. 2019.
[Oral Communication]
Komarova, I; Horvath, A; Leber, B; Feldbacher, N, Vermeren, S; Stadlbauer, V.
Role of bile acids in liver cirrhosis associated neutrophil dysfunction
Doctoral Day of Medical University of Graz; NOV 21, 2019; Graz, AUSTRIA. 2019.
[Poster]
Komarova, I; Leber, B; Horvath, A; Posch, A; Streit, A; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V
Improvement of neutrophil function in hepatitis C patients under direct acting anti-viral treatment is associated with hemolysis parameters
J HEPATOL. Journal of Hepatology. 2019; 70(1):E226-E226.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA.
Doi: 10.1016/S0618-8278(19)30422-0
[Poster]
Web of Science
FullText
FullText_MUG
Komarova, I; Leber, B; Horvath, A; Posch, A; Streit, A; Spindelboeck, W; Stiegler, P; Stauber, R; Stadlbauer, V.
Neutrophil function changes are associated with hemolysis in HCV patients receiving DAA treatment
Zeitschrift für Gastroenterologie. 2019; 57(05):e161-e162.-52. Jahrestagung & 30. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie (ÖGGH); JUN 13-15, 2019; Innsbruck, AUSTRIA.
[Poster]
FullText
Stadlbauer, V
Die Leber auf der Intensivstation
Facharztausbildungskurs Block C (Intensivmedizin); OCT 10, 2019; Salzburg. 2019.
[Oral Communication]
Stadlbauer, V
Adipositas und Mikrobiom
Das Mikrobiom in der gastroenterologischen Praxis; SEP 6-7, 2019; Hamburg. 2019.
[Oral Communication]
Stadlbauer, V
Rückblick BMSD 2018
DEPROM 2019; FEB 22-23, 2019; Berlin. 2019.
[Oral Communication]
Stadlbauer, V
Prä- und Probiotika
Ernährungsmedizin; SEP 14, 2019; Wien. 2019.
[Oral Communication]
Stadlbauer, V
Medikamente und Darmflora – verträgt sich das?
Verdauungstag; APR 5, 2019; Wien. 2019.
[Science to Public]
Stadlbauer, V
Mikrobiom und Medikamenteninteraktionen
Verdauungstag; APR 5, 2019; Wien. 2019.
[Oral Communication]
Stadlbauer, V
Adipositas: eine gastrointestinale Infektionserkrankung?
VEÖ Jahrestagung; APR 10, 2019; Wien. 2019.
[Oral Communication]
Stadlbauer, V
Management der Immunsuppression nach Lebertransplantation
LTX Kurs ; JAN 31-FEB 1, 2019; Innsbruck, Austria. 2019.
[Oral Communication]
Stadlbauer, V
Management leberspezifischer Symptome
UPDATE XV Chronisch entzündliche Darmerkrankungen und Hepatologie; MAR 29-30, 2019; Leoben. 2019.
[Oral Communication]
Stadlbauer, V
The gut-liver axis as a novel therapeutic target in chronic liver disease and diabesity
Webinar Invivo; May 1, 2019; London (als Webinar von Graz aus). 2019.
[Oral Communication]
Stadlbauer, V
Das Mikrobiom und Medikamente
Burgenländischer Ärztetag; MAY 11, 2019; Deutschkreutz. 2019.
[Oral Communication]
Stadlbauer, V
Das Mikrobiom bei chronischen Lebererkrankungen
Fachakademie für Ärzte; MAY 23-24, 2019; Graz. 2019.
[Oral Communication]
Stadlbauer, V
Schwerpunkt Organspende: Organspende in Österreich, Management potentieller OrganspenderInnen
Fortbildung LKH Graz II Standort West; DEZ 10, 2019; Graz. 2019.
[Oral Communication]
Stadlbauer, V
Mikrobiom und das Immunsystem - Welche Bedeutung hat das Mikrobiom für die Immuntherapie?
Update Lungenkarzinom; SEP 3, 2019; Graz. 2019.
[Oral Communication]
Stadlbauer, V
Lebertransplantation: Organspende - Indikation - Ablauf - Nachsorge
Fortbildung LKH Feldbach; DEZ 16, 2019; Feldbach. 2019.
[Oral Communication]
Stadlbauer, V
The gut-liver axis as a novel therapeutic target in chronic liver disease and diabesity
Partnering Day; SEP 5, 2019; Graz. 2019.
[Oral Communication]
Stadlbauer, V
The gut-liver axis in chronic liver disease: Pathophysiology and therapeutic target
International Student Congress; MAY 30 - JUN 1, 2019; Graz. 2019.
[Keynote lecture]
Stadlbauer, V
Chronische Medikamenteneinnahme: Der säurefreie Magen
DEPROM 2019; FEB 22-23, 2019; Berlin. 2019.
[Oral Communication]
Stadlbauer, V
Salz oder kein Salz bei Zirrhose?
Frühling der Hepatologie; MAR 16, 2019; Graz. 2019.
[Oral Communication]
Stadlbauer, V
Immuntherapie und Mikrobiom
36. Ernährungskongress des Verbands der Diaetologen Österreichs ; MAR 29, 2019; Wien. 2019.
[Oral Communication]
Stadlbauer, V
Mikrobiommodulation durch Probiotika in der Praxis
Update Refresher Innere Medizin; APR 12, 2019; Graz. 2019.
[Oral Communication]
Stadlbauer, V
Virushepatitiden
Update Refresher Innere Medizin; MAY 22, 2019; Wien. 2019.
[Oral Communication]
Stadlbauer, V
Probiotika in der Praxis
Update Refresher Innere Medizin; MAY 24, 2019; Köln. 2019.
[Oral Communication]
Stadlbauer, V
Einfluss von Medikamenten auf das Mikrobiom
Interne Fortbildung BHB Wien; FEB 20, 2019; Wien. 2019.
[Oral Communication]
Stadlbauer, V
Mikrobiom und Alter
15. Internationales Symposium der österreichischen Gesellschaft für probiotische Medizin; NOV 30, 2019; Wien. 2019.
[Oral Communication]
Stadlbauer, V
Kontroversielle Indikationen - Hepatologie
3. Grazer Transplantationssymposium; NOV 30, 2019; Graz. 2019.
[Oral Communication]
Stadlbauer, V.
PPI und Mikrobiom
Bezirksärztetagung Graz Umgebung; JAN 28, 2019; Friesach, Austria. 2019.
[Oral Communication]
Stadlbauer, V.
Mikrobiom
Fortbildung LKH Fürstenfeld; NOV 28, 2019; Fürstenfeld. 2019.
[Oral Communication]
Stadlbauer V
Abklärung erhöhter Leberwerte
FOMF Update Refresher Allgemeinmedizin; NOV 6, 2019; Wien. 2019.
[Oral Communication]
Stadlbauer V
Hepatische Enzephalopathie und Mikrobiom
Wrap Up AASLD 2018; 12.1.2019; Wien. 2019.
[Oral Communication]
STADLBAUER, V
Medikamente und Mikrobiom
Graz Zahn 2019; APR 26-27, 2019; Graz. 2019.
[Oral Communication]
Stadlbauer, V.
Das Mikrobiom bei Diabesity
Medizin im Museum; NOV 23, 2019; Wien. 2019.
[Oral Communication]
Steiner, K; Pfleger, A; Stadlbauer-Köllner, V; Schwinger, W; Eber, E
EBV-induziertes Hämophagozytosesyndrom mit subakutem
Leberversagen und tubulointerstitieller Nephritis bei zystischer
Fibrose.
Monatsschrift Kinderheilkunde. 2019; 167 (Suppl 5): S304--57. Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde (ÖGKJ); SEP 19-21, 2019; Klagenfurt, AUSTRIA.
[Oral Communication]
Traub J, Bergheim I, Stadlbauer V.
COMPARISON OF THE DEFINITION OF SARCOPENIA ON CIRRHOTIC PATIENTS REGARDING THE EUROPEAN CONSENSUS VALUES 2010 AND 2019
Clinical Nutrition. 2019; 38(1):59-296.-ESPEN Congress; AUG 31-SEP 3; Krakow, Poland.
[Poster]
FullText
Horvath, A; Durdevic, M; Leber, B; di Vora, KG; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V
Changes in the intestinal microbiome during a multispecies probiotic intervention in compensated cirrhosis
Theodor Escherich Symposium; NOV 8-9, 2018; Graz, Austria. 2018.
[Poster]
Horvath, A; Leber, B; Komarova, I; Schmerboeck, B; Feldbacher, N; Rainer, R; Blesl, A; Stiegler, P; Stadlbauer, V
Agitated but not fully functional: The effect of binge drinking on neutrophils of healthy young adults
Nordmann Award Meeting; OKT 11-12, 2018; Louvain-la-Neuve, Belgium. 2018.
[Oral Communication]
Horvath, A; Rainer, F; Leber, B; Schmerböck, B; Spindelböck, W; Stauber, RE; Stiegler, P; Stadlbauer, V
AGRA – a functional biomarker for humoral immune function predicts the development of severe bacterial infections in cirrhosis
Z Gastroenterol 2018; 56(05): e38. 2018; -Jahrestagung der Österreichischen Gesellschaft der Gastroenterologie und Hepatologie; JUN 14-16, 2018; Salzburg, Austria.
[Poster]
Horvath, A; Rainer, F; Leber, B; Schmerboeck, B; Spindelboeck, W; Stauber, R; Stiegler, P; Stadlbauer, V
ACELLULAR GROWTH RETARDATION ABILITY (AGRA) PREDICTS THE OCCURRENCE OF SEVERE BACTERIAL INFECTIONS IN CIRRHOSIS.
TRANSPL INT. 2018; 31: 8-9.
[Poster]
Web of Science
Horvath, A; Rainer, F; Leber, B; Schmerboeck, B; Stiegler, P; Stadlbauer, V
Acellular growth retardation ability (AGRA), a novel biomarker for humoral immune function, predicts the occurrence of severe bacterial infections in cirrhosis
J HEPATOL. 2018; 68: S692-S692.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE.
Doi: 10.1016/S0168-8278(18)31646-5
[Oral Communication]
Web of Science
FullText
FullText_MUG
Horvath, A; Stadtmauer, V
Probiotics in clinical application
: Probiotics in diabesity
Berchtesgaden Microbiome Science Days; Berchtesgaden. 2018.
[Oral Communication]
Komarova, I; Horvath, A; Krones, E; Fickert, P; Leber, B; Schmerböck, B; Durchschein, F; Zollner, G; Stauber, R; Spindelboeck, W;
Douschan, P; Stiegler, P; Kniepeiss, D; Stojakovic, T; Fauler, G; Stadlbauer, V
Bile acids composition and neutrophil function in different etiologies of liver cirrhosis.
JOINT DK-RETREAT MCBO/MOLIN/IAI “Cancer, Inflammation, Immunity”; JAN 13-17, 2018; Universitätszentrum OBERGURGL, Tirol, AUSTRIA. 2018.
[Poster]
Komarova, I; Horvath, A; Krones, E; Leber, B; Schmerboeck, B; Durchschein, F; Zollner, G; Stauber, R; Spindelboeck, W; Douschan, P; Stiegler, P; Kniepeiss, D; Stojakovic, T; Fauler, G; Fickert, P; Stadlbauer, V
Functional response of neutrophils is associated with serum bile acids profile in liver cirrhotic patients
Zeitschrift für Gastroenterologie. 2018; 56(05):e28-e28.-51. ÖGGH Jahrestagung; JUN 14–16, 2018; Salzburg, AUSTRIA.
[Oral Communication]
FullText
Komarova, I; Horvath, A; Krones, E; Leber, B; Schmerboeck, B;
Durchschein, F; Zollner, G; Stauber,RE; Spindelböck, W;
Douschan, P; Stiegler, P; Kniepeiss, D; Stojakovic, T; Fauler, G;
Stadlbauer, V
Changes of bile acids profile in different etiologies of liver cirrhosis and its association with neutrophil response
JOURNAL OF HEPATOLOGY. 2018; 68(SUPP.1):S473-S473.-The International Liver Congress; APR 11–15, 2018; Paris, FRANCE.
Doi: 10.1016/S0168-8278(18)31193-0
[Poster]
Web of Science
FullText
FullText_MUG
Leber, B; Horvath, A; Schmerboeck, B; Posch, A; Streit, A; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V
Direct acting anti-viral therapy rescues neutrophil dysfunction in hepatitis C infection by reduction of heamolysis
J HEPATOL. 2018; 68: S326-S327.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE.
Doi: 10.1016/S0168-8278(18)30873-0
[Poster]
Web of Science
FullText
FullText_MUG
Leber, B; Horvath, A; Schmerboeck, B; Posch, A; Streit, A; Spindelboeck, W; Stiegler, P; Stauber, RE; Stadlbauer, V
Direct acting anti-viral therapy rescues neutrophil dysfunction in HCV infection.
Journal of Hepatology, Volume 68, Supplement 1, S1-S926. 2018; 68(Suppl1):326-327.-The International Liver Congress, 2018; APR 11-18, 2018; Paris, France.
[Poster]
Pferschy, P; Tripolt, N; Url, J; Aberer, F; Hogenauer, C; Schreiber, F; Eherer, A; Sourij, C; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal liner in obese subjects with type 2 diabetes - Sustainable effects on insulin sensitivity after explantation
WIEN KLIN WOCHENSCHR. 2018; 130: 374-374.
[Oral Communication]
Web of Science
Rainer, F; Horvath, A; Bashir, M; Leber, B; Schmerboeck, B; Blesl, A; Madl, T; Klymiuk, I; Groselj-Strele, A; Durdevic, M; Gronbaek, H; Moller, HJ; Freedber, DE; Abrams, JA; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V
Loss of colonization resistance in cirrhosis facilitates proton pump inhibitor-associated oralization of the colonic microbiome
J HEPATOL. 2018; 68: S700-S700.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE.
Doi: 10.1016/S0168-8278(18)31663-5
[Poster]
Web of Science
FullText
FullText_MUG
Sassmann, T; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Revelant, F; Stadlbauer, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H; Douschan, P
Diastolic dysfunction and cardiopulmonary exercise capacity in patients with advanced liver disease-results from a prospective cross-sectional cohort
WIEN KLIN WOCHENSCHR. 2018; 130(19-20):627-627.-ÖGP Jahrestagung; OKT 18-20, 2018; Linz, Austria.
[Poster]
Web of Science
Sassmann, T; Kovacs, G; Stauber, RE; Revelant, F; Foris, V; Pfeiffer, S; Gruber, F; Stadlbauer, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H; Douschan, P;
Impact of diastolic dysfunction on exercise capacity in patients with liver cirrhosis
European Respiratory Journal. 2018; 52(sup 62):-ERS International Congress; SEP 15 - 19, 2018; Paris, France.
Doi: 10.1183/13993003.congress-2018.PA2486
[Poster]
Web of Science
FullText
FullText_MUG
Stadlbauer, V
Aszites und hepatische Enzephalopathie
Post AASLD 2018; JAN 14, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V
Alzheimer und Demenz - Vergesslichkeit aus dem Darm
Lactulose – das Multitalent für den Darm/Das Mikrobiom als Steuerzentrale des Körpers; Oct 6, 2018; Linz. 2018.
[Oral Communication]
Stadlbauer, V
Frauen in der Medizin
Young ÖGGH; SEP 9, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V
Protonenpumpenhemmer und das Mikrobiom: eine gefährliche Liaison?
Mikrobiota Tagung; APR 21, 2018; Graz. 2018.
[Oral Communication]
Stadlbauer, V
Die Bedeutung des Mikrobioms in der Behandlung von Lebererkrankungen
Fortbildungsveranstaltung der Österreichischen Apothekerkammer; MAR 19, 2018; Klagenfurt. 2018.
[Keynote lecture]
Stadlbauer, V
Probiotika bei Lebererkrankungen
Medizin im Museum; Apr 14, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V
Beispiel medikamentöse Übertherapie: Braucht jeder Intensivpatient PPIs?
Wiener Intensivmedizinische Tage; FEB 14.17, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V.
Probiotic therapy in liver cirrhosis: Is it safe and effective?
Partnering Day 2018; SEP 6, 2018; Graz. 2018.
[Oral Communication]
Stadlbauer, V.
Abklärung erhöhte Leberwerte
Update Refresher; NOV 9, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V.
Unterschiede und Gemeinsamkeiten zwischen Probiotischen Nahrungsergänzungsmitteln und Arzneimitteln
Jahrestagung DGMIM 2018; SEP 28, 2018; Stuttgart. 2018.
[Keynote lecture]
Stadlbauer, V.
Medikamente und das Mikrobiom
Fortbildung LKH Oberwart; SEP 25, 2018; Oberwart. 2018.
[Oral Communication]
Stadlbauer, V.
Pro- und Präbiotika
Diplom Ernähurngsmedizin; SEP 15, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V.
Metabolische Lebererkrankungen nach Lebertransplantation.
2. Transplant Symposium Graz; NOV 17, 2018; Graz. 2018.
[Oral Communication]
Stadlbauer, V.
Proton pump inhibitors and the microbiome: A dangerous liaison?
Partnering Day Amsterdam; OCT 25-26, 2018; Amsterdam. 2018.
[Oral Communication]
Stadlbauer, V.
Antibiotika und PPI: Wie können wir unser Mikrobiom schützen?
Ärztliche Fortbildung für Praktiker und Internisten im EKH Klagenfurt; Feb 20, 2018; Klagenfurt. 2018.
[Keynote lecture]
Stadlbauer, V.
Chronische Lebererkrankungen
Gesellschaft zum Goldenen Kreuze; Oct 17, 2018; Wien. 2018.
[Science to Public]
Stadlbauer, V.
Das Mikrobiom bei chronischen Lebererkrankungen
Fachakademie für Ärzte; Oct 7, 2018; Graz. 2018.
[Keynote lecture]
Stadlbauer, V.
Leberfunktionsstörungen – Endstation Leberzirrhose
Fortbildung Apothekerkammer; Sep 27, 2018; Graz. 2018.
[Oral Communication]
Stadlbauer, V.
Einfluss von Medikamenten auf das Mikrobiom
Menopause Kongress; DEC 6, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V.
Mikrobiom beim metabolischen Syndrom
Jahrestagung ÖPROM; DEC 1, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V.
Das Mikrobiom bei chronischen Lebererkrankungen
Ärzte Fachakademie; APR 28, 2018; Graz. 2018.
[Oral Communication]
Stadlbauer, V.
Protonenpumpenhemmer und das Mikrobiom: Wie können wir die Nebenwirkungen managen?
„Darm-Leber-Hirn“ – Ihr Abend-Symposium bei der DGIM 2018; APR 16, 2018; Mannheim. 2018.
[Oral Communication]
Stadlbauer, V.
De novo Infektionen post LTX: Adaptation der Immunsuppression
Frühling der Hepatologie 2018; MAR 17, 2018; Graz. 2018.
[Oral Communication]
Stadlbauer, V.
Einfluss von Nährstoffen und Medikamenten auf das Mikrobiom
35. ERNÄHRUNGSKONGRESS
DES VERBANDES DER DIAETOLOGEN ÖSTERREICHS
; MAR 8-9, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V.
Rückblick Berchtesgaden Microbiome Science Days
4. Deutsche Mikrobiomtage; FEb 22-23, 2018; Berlin. 2018.
[Oral Communication]
Stadlbauer, V.
Probiotics in liver disease
Gut Microbiota for Health World Summit; MAR 10-11, 2018; Rom. 2018.
[Oral Communication]
Stadlbauer, V.
Protonenpumpenhemmer und das Mikrobiom: eine gefährliche Liaison?
Fortbildung Rehazentrum Bad Tatzmannsdorf; MAR 1, 2018; Bad Tatzmannsdorf. 2018.
[Oral Communication]
Stadlbauer, V.
Protonenpumpenhemmer und das Mikrobiom: eine gefährliche Liaison?
4. Deutsche Mikrobiomtage; FEB 22-23, 2018; Berlin. 2018.
[Oral Communication]
Stadlbauer, V.
Ballaststoffe, Pro- und Präbiotika: was wirkt?
35. ERNÄHRUNGSKONGRESS
DES VERBANDES DER DIAETOLOGEN ÖSTERREICHS; MAR 8-9, 2018; Wien. 2018.
[Oral Communication]
Stadlbauer, V.
Von der Statistik in die klinische Praxis DAAs im medizinischen Alltag
KLINISCHE PUBLIKATIONEN VERSTEHEN; MAR 5 2018; Graz. 2018.
[Oral Communication]
Tripolt, NJ; Aberer, F; Pferschy, PN; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Sourij, C; Svehlikova, E; Obermayer, AM; Stadlbauer-Köllner, V; Sourij, H
EndoBarrier® Gastrointestinal Liner in Obese Subjects with Type 2 Diabetes - Short and Midterm Effects on Glucose Metabolism
46. ÖDG Jahrestagung 2018; NOV 15-17; Salzburg, AUSTRIA. 2018.
[Oral Communication]
Tripolt, NJ; Aberer, F; Url, J; Pferschy, PN; Högenauer, C; Schreiber, F; Eherer, A; Sourij, C; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, H;
Changes in insulin sensitivity and beta-cell function within 9 months after duodeno-jejunal bypass liner implantation in patients with type 2 diabetes
2nd Donau Symposium & 3rd CBmed Biomarker Conference 2018; MAR 14-16, 2018; Vienna, Park Hyatt Vienna. 2018.
[Oral Communication]
Blesl, A; Horvath, A; Jüngst, C; Leber, B; Schmerböck, B; Tawdrous, M; Stiegler, P; Rainer, F; Spindelböck, W; Fickert, P; Lammert, F; Stadlbauer, V
Dysbiosis of the gut microbiota and increased gut permeability characterize secondary sclerosing cholangitis of critically ill patients (SSC-CIP)
EASL; 19.-23.4. 2017; Amsterdam. 2017.
[Poster]
Blesl, A; Horvath, A; Jüngst, C; Leber, B; Schmerböck, B; Tawdrous, M; Stiegler; P, Rainer, F; Spindelböck, W; Fickert, P.; Lammert, F; Stadlbauer, V
Increased gut permeability and changes of the gut microbiota in secondary sclerosing cholangitis of critically ill patients (SSC-CIP)
Zeitschrift für Gastroenterologie. 2017; 5(55):28e-56e.-ÖGGH; Jun 8-10, 2017; AUSTRIA.
[Poster]
Blesl, A; Horvath, A; Jungst, C; Leber, B; Schmerboeck, B; Tawdrous, M; Stiegler, P; Rainer, F; Spindelboeck, W; Fickert, P; Lammert, F; Reichert, M; Stadlbauer, V.
Dysbiosis of the gut microbiota and increased gut permeability characterize secondary sclerosing cholangitis in critically ill patients (SSC-CIP)
J HEPATOL. 2017; 66(1):S354-S355.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)31046-2
[Poster]
Web of Science
FullText
FullText_MUG
Blesl, A; Horvath, A; Jungst, C; Rainer, F; Leber, B; Stadlbauer, V
Impaired gut permeability and alterations of the gut microbiota in secondary sclerosing cholangitis of critically ill patients (SSC-CIP)
MED KLIN-INTENSIVMED. 2017; 112(4):396-396.
[Poster]
Web of Science
Blesl A; Horvath, A; Jüngst, Ch; Leber, B; Schmerböck, B; Tawdrous, M; Stiegler, P; Rainer, F; Spindelböck, W; Fickert, P; Lammert, F; Stadlbauer, V
Impaired gut permeability and alterations of the gut microbiota in secondary sclerosing cholangitis of critically ill patients (SSC-CIP)
ÖGIAIN; JUN 7-10, 2017; Innsbruck. 2017.
[Poster]
Blesl, C; Mörkl, S; Tmava, A; Rauter, D; Wurm, W; Baranyi, A; Meinitzer, A; Stadlbauer-Köllner, V; Schöggl, H; Kapfhammer, HP; Painold, A; Fitz, W; Holl AK
Pankreaskarzinom und Depression – eine neuroendokrine Hypothese
17. Jahrestagung der Österreichischen GEsellschaft für Psychiatrie, Psychotherapie und Psychosomatik; APR 26-29, 2017; Gmunden. 2017.
[Poster]
Blesl, C; Tmava, A; Baranyi, A; Meinitzer, A; Painold, A; Holl, A; Stadlbauer-Kollner, V; Kapfhammer, HP; Morkl, S
The Kynurenine pathway in pancreatic carcinoma
EUR PSYCHIAT. 2017; 41: S480-S480.
Doi: 10.1016/j.eurpsy.2017.01.564
[Poster]
Web of Science
FullText
FullText_MUG
Bluemel, S; Wang, L; Martino, C; Lee, S; Williams, B; Horvath, A; Stadlbauer, V; Zengler, K; Schnabl, B
The Role of Intestinal Reg3 lectins for Non-Alcoholic-Steatohepatitis
HEPATOLOGY. 2017; 66: 452A-453A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC.
[Poster]
Web of Science
Douschan, P; Kovacs, G; Stadlbauer, V; Kniepeiss, D; Krones, E; Durchschein, F; Rainer, F; Spindelboeck, W; Wagner, M; Zollner, G; Avian, A; Fickert, P; Olschewski, A; Olschewski, H; Stauber, RE
Exercise capacity and exercise hemodynamics in the screening for pulmonary vascular disease (PVD) in patients with portal hypertension - results from a prospective cross-sectional study
J HEPATOL. 2017; 66(1):S568-S569.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)31556-8
[Poster]
Web of Science
FullText
FullText_MUG
Douschan, P; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Sassmann, T; Revelant, F; Stadlbauer, V; Kniepeiss, D; Fickert, P; Avian, A; Olschewski, A; Olschewski, H
Impact of chronic liver disease on pulmonary hemodynamics and exercise tolerance - results from a prospective cross-sectional study
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):768-769.
[Poster]
Web of Science
Douschan, P; Kovacs, G; Stauber, R; Foris, V; Pfeiffer, S; Gruber, F; Stadlbauer-Kollner, V; Kniepeiss, D; Zollner, G; Fickert, P; Avian, A; Olschewski, A; Olschewski, H
Exercise Hemodynamics In The Screening For Pulmonary Vascular Disease In Patients With Portal Hypertension - Results From A Prospective Cross-Sectional Study
AM J RESP CRIT CARE. 2017; 195: -International Conference of the American-Thoracic-Society (ATS); MAY 19-24, 2017; Washington, USA.
[Oral Communication]
Web of Science
Foessl, I; Ulbing, M; Kirsch, A; Schweighofer, N; Leber, B; Lemesch, S; Rosenkranz, A; Eller, K; Müller, H; Stadlbauer, V; Obermayer-Pietsch, B;
Micro-RNA Targets Associated with Bone Metabolism in Chronic Kidney Disease Patients Before and After Kidney Transplantation.
8th Skeletal Endocrinology meeting, 3rd Translational ESE Bone Course. 2017; Apr 7-8, 2017; Mantova, ITALY.
[Poster]
Foessl, I; Ulbing, M; Kirsch, A; Schweighofer, N; Leber, B; Lemesch, S; Rosenkranz, A; Eller, K; Müller, H; Stadlbauer, V; Obermayer-Pietsch, B;
Micro-RNA Targets Associated with Bone Metabolism in Chronic Kidney Disease Patients Before and After Kidney Transplantation.
ESE Summer School on Endocrinology 2017 Venue. 2017; -ESE Summer School; JUL 30-AUG 3, 2017; Berlin.
[Poster]
Horvath, A; Bashir, M; Schmerboeck, B; Rainer, F; Krones, E; Baumann-Durchschein, F; Douschan, P; Spindelboeck, W; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Leber, B; Stadlbauer, V
Intestinal colonisation by Veillonella spp. is predictive for mortality in stable cirrhosis and could be partially reduced by a multispecies probiotic in a randomized placebo controlled trial
J HEPATOL. 2017; 66(1):S128-S128.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)30524-X
[Poster]
Web of Science
FullText
FullText_MUG
Horvath, A; Durdevic, M; Leber, B; Schmerboeck, B; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer V
Multispecies probiotic enriches the microbiome with Lactobacillus and Lactococcus and reduces Enterococcus abundance in patients with liver cirrhosis: Results of a randomized, double-blind, placebo-controlled trial.
Volume 5, Issue 5_suppl, October 2017. 2017; -UEG Week 2017; OCT 28-NOV 1, 2017; Barcelona.
[Poster]
Horvath, A; Grande, P; Rainer, F; Blesl, A; Meinitzer, A; Leber, B; Schmerböck, B; Komarova, I; Fickert, P; Stiegler, P; Wagner, M; Stadlbauer, V
FGF21 in acute and chronic alcohol consumption
Zeitschrift für Gastroenterologie, Ausgabe 05, Volume 55, Mai 2017. 2017; -Jahrestagung der ÖGGH; JUN 9-10 2017; Linz.
[Poster]
Horvath, A; Rainer, F; , Bashir, M; Leber, B; Schmerboeck, B; Grønbæk, H; Møller, HJ; Madl, T; Groselj-Strele, A; Fickert, P; Stiegler, P; Stadlbauer, V
LONG-TERM PROTON PUMP INHIBITOR USE INCREASES INTESTINAL DYSBIOSIS, GUT PERMEABILITY, INFLAMMATION AND MORTALITY IN PATIENTS WITH LIVER CIRRHOSIS.
UEG Journal, Volume: 5 issue: 5_suppl, page(s): A1-A160. 2017; -UEG Week 2017; OCT 28-NOV 1, 2017; Barcelona.
[Oral Communication]
Horvath, A; Rainer, F; Bashir, M; Leber, B; Schmerboeck, B; Grønbæk, H; Madl, T; Fickert, P; Stiegler, P; Stadlbauer, V
Protonenpumpenhemmer bei Leberzirrhose: Einfluss auf Dysbiose, Darmpermeabilität, Inflammation und Mortalität
Zeitschrift für Gastroenterologie, Ausgabe 05, Volume 55; Mai 2017. 2017; -Jahrestagung der ÖGGH; JUN 9-10 2017; Linz, Austria.
[Oral Communication]
Horvath, A; Stadlbauer V
Proton pump inhibitors and the microbiome: A dangerous liaison?.
Berchtesgaden Microbiome Science Days 2017; SEP 22-23, 2017; Bertesgaden, Germany. 2017.
[Oral Communication]
Jungst, C; Stadlbauer, V; Reichert, M; Weber, S; Ofner-Ziegenfuss, L; Voigtlander, T; Spindelbock, W; Fickert, P; Kirchner, G; Lammert, F; Lankisch, TO; Krawczyk, M
NOD2 variants as novel genetic risk factors for secondary sclerosing cholangitis in critically ill patients
J HEPATOL. 2017; 66(1):S358-S358.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
Leber, B; Horvath, A; Schmerbock, B; Tawdrous, M; Streit, A; Posch, A; Fickert, P; Spindelbock, W; Stiegler, P; Stauber, RE; Stadlbauer, V
Direct acting antivirals improve neutrophil phagocytic capacity in chronic hepatitis C
J HEPATOL. 2017; 66(1):S293-S293.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)30902-9
[Poster]
Web of Science
FullText
FullText_MUG
Leber, B; Horvath, A; Schmerböck, B; Tawdrous, M; Streit, A; Posch, A; Fickert, P; Spindelböck, W; Stiegler, P; Stauber, RE; Stadlbauer, V
Neutrophil phagocytic capacity in chronic hepatitis C improves under direct acting antivirals
Zeitschrift für Gastroenterologie. 2017; 55(5):-ÖGGH; JUN 8-10, 2017; Linz, Austria.
[Poster]
Lindheim, L
Abnormal gut microbiome in PCOS
Androgen Excess and PCOS Society Update Meeting ; MAR 31, 2017; Orlando, FL, USA. 2017.
[Oral Communication]
Lindheim, L; Bashir, M; Münzker, J; Haudum, CW; Trummer, C; Zachhuber, V; Leber, B; Horvath, A; Pieber, TR; Gorkiewicz, G; Stadlbauer, V; Obermayer-Pietsch, B;
PCOS – polycystic ovary syndrome and gut microbiome
Berchtesgaden Microbiome Science Days; Sep 22-23, 2017; Berchtesgaden. 2017.
[Oral Communication]
Pferschy, P; Tripolt, N; Aberer, F; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, A; Stadlbauer, V; Sourij, C; Sourij, H;
Endobarrier bei adipösen Personen mit Typ-2 Diabetes: Kurz- und mittelfristige Auswirkungen auf den Glukosestoffwechsel
18. Jahrestagung der Österreichischen Adipositas Gesellschaft; OCT 20-21, 2017; Tech Gate Vienna. 2017.
[Oral Communication]
Pferschy, PN; Tripolt, NJ; Aberer, F; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, C; Sourij, H
Endobarrier in obese People with Type-2 Diabetes: Short- and Medium-term Effects on the Glucose Metabolism
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):732-732.
[Poster]
Web of Science
Rainer, F; Horvath, A; Sandahl, TD; Leber, B; Schmerboeck, B; Blesl, A; Krones, E; Baumann-Durchschein, F; Douschan, P; Spindelboeck, W; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Moller, HJ; Gronbaek, H; Stadlbauer, V
Macrophage activation markers sCD163 and mannose receptor predict survival and correlate with markers of gut permeability in patients with liver cirrhosis
J HEPATOL. 2017; 66(1):S368-S369.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)31080-2
[Poster]
Web of Science
FullText
FullText_MUG
Sarah Stryeck, Angela Horvath, Bettina Leber, Vanessa Stadlbauer, Tobias Madl
NMR spectroscopy enables simultaneous quantification of lactulose, sucrose and mannitol in urine for diagnosis of intestinal and gastric permeability
Austrian Proteomics and Metabolomics Resesarch Symposium; SEP 6-8, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Stadlbauer, V
PPI und Mikrobiom: eine gefährliche Liaison
; OCT 19, 2017; Graz. 2017.
[Oral Communication]
Stadlbauer, V
Hepatitis C Extrahepatische Manifestationen
; NOV 15, 2017; Graz. 2017.
[Oral Communication]
Stadlbauer, V
Antibiotika und PPI: Wie können wir unser Mikrobiom schützen?
; SEP 27, 2017; Bad Waltersdorf. 2017.
[Oral Communication]
Stadlbauer, V
Virushepatitis: Gefahrenpotential bei Tumortherapien
; SEP 13, 2017; Graz. 2017.
[Oral Communication]
Stadlbauer, V
Nachsorge nach Lebertransplantation
Transplantationstag; SEP9, 2017; Graz. 2017.
[Oral Communication]
Stadlbauer, V
Probiotika in der Intensivmedizin
Intensivmedizin; JUN 6-9, 2017; Innsbruck. 2017.
[Oral Communication]
Stadlbauer, V
Mikrobiom und Leber
AKE Tagung; MAY 18, 2017; Wien. 2017.
[Oral Communication]
Stadlbauer, V
Leberzirrhose - eine Erkrankung des Darms?
; FEB 21, 2017; Wien. 2017.
[Oral Communication]
Stadlbauer, V
ACLF Definition und Diagnose "Wo wollen wir hin"
Frühling der Hepatologie 2017; MAR 18, 2017; Graz. 2017.
[Oral Communication]
Stadlbauer, V
Hepatische Enzephalopathie
Fortbildungstage der Ärztekammer Steiermark; Sep 12, 2017; Graz. 2017.
[Oral Communication]
Stadlbauer, V
Die Darm-Leber-Achse als pathophysiologisches und therapeutisches Konzept
Fachakademie für Ärzte; SEP 11, 2017; Wien. 2017.
[Oral Communication]
Stadlbauer, V
Exokrine Pankreasinsuffizienz
50. Jahrestagung der ÖGGH; JUN 7-10, 2017; Linz. 2017.
[Oral Communication]
Stadlbauer, V
Leberzirrhose: Eine Erkrankung des Darms
; MAY 18, 2017; Wien. 2017.
[Oral Communication]
Stadlbauer, V
Das Mikrobiom: Einführung und Beispiele anhand der Darm-Leber-Achse
; MAY 6, 2017; Frankfurt. 2017.
[Oral Communication]
Stadlbauer, V
Protonenpumpenhemmer und das Mikrobiom: eine gefährliche Liaison
123. Kongress der DGIM; APR29 -MAY 2, 2017; Mannheim. 2017.
[Oral Communication]
Stadlbauer, V
Die Leber
Minimed; JAN 31, 2017; Graz. 2017.
[Oral Communication]
Stadlbauer, V
Update Mikrobiom
Menopause; Dec 8, 2017; Wien. 2017.
[Oral Communication]
Stadlbauer, V
Wichtige Lebererkrankungen: Diagnose und Therapie
; DEC 2, 2017; 2017.
[Oral Communication]
Stadlbauer, V
Protonenpumpenhemmer und das Mikrobiom: Eine gefährliche Liaison
; DEC 2, 2017; Wien. 2017.
[Oral Communication]
Stadlbauer, V
Macht das Mikrobiom die Leber krank?
; NOV 24, 2017; Graz. 2017.
[Oral Communication]
Stadlbauer, V
Probiotic therapy
First EASL NAFLD Summit: Target-oriented approach to diagnosis and pharmacotherapy of NASH, a dialogue between academia and industry; NOV 9-11, 2017; Rom. 2017.
[Oral Communication]
Stadlbauer, V
Protonenpumpenhemmer und das Mikrobiom: eine gefährliche Liason
; OCT 19, 2017; Unterpremstätten. 2017.
[Oral Communication]
Stadlbauer, V
Medikamentöse Therapie des Portalen Hypertonie
; APR 1, 2017; Leoben. 2017.
[Oral Communication]
Stadlbauer, V
Mikrobiomtherapie bei fortgeschrittener Leberzirrhose
DeProm; FEB 24-25, 2017; Berlin. 2017.
[Oral Communication]
Stadlbauer, V
Aszites und hepatische Enzephalopathie
post AASLD Meeting; JAN 12, 2017; Linz. 2017.
[Oral Communication]
Stadlbauer, V.
Antibiotika-Colitis
Wiener Intensivmedizinische Tage; FEB 15, 2017; Wien. 2017.
[Oral Communication]
Stadlbauer, V.
Antibiotika und PPI: Wie können wir unser Mikrobiom schützen?
; JUN 1, 2017; Deutschlandsberg. 2017.
[Oral Communication]
Stadlbauer, V.
Aszites und hepatische Enzephalopathie, was steckt dahinter?
Lebertag 2017; FEB 25, 2017; Wien. 2017.
[Oral Communication]
Stadlbauer, V;
Das Mikrobiom von A bis Z
; JAN 24, 2017; Linz. 2017.
[Oral Communication]
Stadlbauer, V; Schmerbock, B; Leber, B; Kipperer, M; Stiegler, P; Posch, A; Streit, A; Spindelbock, W; Fickert, P; Stauber, R
Drop of FGF19 levels in patients with HCC development following DAA therapy for chronic hepatitis C
J HEPATOL. 2017; 66(1):S710-S711.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)31903-7
[Poster]
Web of Science
FullText
FullText_MUG
Thabut, D; Stadlbauer, V; Bhamidimarri, KR; Potthoff, A; Bukofzer, S
Geographic Differences for Patients Enrolled in STOP-HE: A Randomized, Phase 2 Study of OCR-002 for Hepatic Encephalopathy
HEPATOLOGY. 2017; 66: 274A-274A.-68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; OCT 20-24, 2017; Washington, DC.
[Poster]
Web of Science
Tripolt, N; Aberer, F; Pferschy, P; Sourij, C; Url, J; Hogenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal bypass-liner in obese subjects with type 2 diabetes: short- and mid-term effects on glucose metabolism
WIEN KLIN WOCHENSCHR. 2017; 129: 161-161.
[Poster]
Web of Science
FullText
Tripolt, N; Aberer, F; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Sourij, C; Obermayer, AM; Stadlbauer, V; Kojzar, H; Pferschy, P; Sourij, H
EndoBarrier in obese subjects with type 2 Diabetes: Short-term effects on Glucose metabolism - a Pilot trial
2nd CBmed Biomarker Conference Graz; Feb 13, 2017; Medical University of Graz, Hörsaalzentrum at LKH-Klinikum Graz. 2017.
[Poster]
FullText
Tripolt, N; Aberer, F; Url, J; Pferschy, P; Hogenauer, C; Schreiber, F; Eherer, A; Sourij, C; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal bypass-liner in obese subjects with type 2 diabetes: short- and mid-term effects on glucose metabolism
WIEN KLIN WOCHENSCHR. 2017; 129: S123-S123.
Web of Science
Tripolt, NJ; Aberer, F; Pferschy, P; Sourij, C; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, M; Stadlbauer-Köllner, V; Sourij, H
Endobarrier® gastrointestinal bypass-liner in obese subjects with type 2 diabetes: Short- and mid-term effects on glucose metabolism
45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18; Salzburg. 2017.
[Poster]
Grande, P; Horvath, A; Wagner, M; Stadlbauer, V
FGF21 and its connection to alcohol consumption
WIEN KLIN WOCHENSCHR. 2016; 128: S384-S384.
[Poster]
Web of Science
Grande, P; Horvath, A; Wagner, M; Stiegler, P; Stadlbauer, V
FGF21 AND ITS CONNECTION TO ALCOHOL CONSUMPTION
TRANSPL INT. 2016; 29: 13-13.
[Poster]
Web of Science
Grgic-Mustafic, R; Kahn, J; Podbregar, M; Holobar, A; Stauber, R; Fickert, P; Stadlbauer-Kollner, V; Nwoha, B; Muller, H; Kniepeiss, D
A NEW METHOD FOR THE DETERMINATION AND MONITORING OF THE AMMONIA IN THE EXHALED AIR
TRANSPL INT. .. 2016; 29: 18-18.
[Poster]
Web of Science
Grgic-Mustafic R, Kahn J, Podbregar M, Holobar A, Stauber R, Fickert P, Stadlbauer-Köllner V, Nwoha B, Müller H, Kniepeiss D
Eine neue Methode zur Bestimmung und Monitoring des Ammoniaks in der Ausatemluft
Special Issue: 30th Annual Meeting of the Austrian Society of Transplantation, Transfusion and Genetics . 2016; 29(S4):1-23.-Austrotransplant; OKT 19-21, 2016; Schladming.
[Poster]
Horvath, A; Bashir, M; Leber, B; Schmerboeck, B; Tawdrous, M; Rainer, F; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V
Probiotic modulation of gut microflora in cirrhosis: Influence on Lactobacilli and Veillonella
Microbiome Science Days; OCT 7-8, 2016; Bertesgaden, Germany. 2016.
[Oral Communication]
Horvath, A; Hartmann, P; Schnabl, B; Stadlbauer, V;
Alcohol consumption and liver damage: A balancing act for the innate immune system
Zeitschrift für Gastroenterologie. 2016; (5):385-520.-Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 16-18, 2016; Wien, Austria.
[Poster]
Horvath, A; Leber, B; Fuchs, D; Schmerboeck, B; Tawdrous, M; Yueksel, O; Sherzay, K; Hartl, A; Lemesch, S; Spindelboeck, W; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Stadlbauer, V
Multispecies probiotic maintains health related quality of life in cirrhosis better than placebo
Journal of Hepatology. 2016; 64(2):425-629.-EASL - ILC2016; APR 12-17, 2016; Barcelona, SPAIN.
[Poster]
Horvath, A; Leber, B; Fuchs, D; Schmerboeck, B; Tawdrous, M; Yueksel, O; Sherzay, K; Hartl, A; Lemesch, S; Spindelboeck, W; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Stadlbauer, V;
MULTISPECIES PROBIOTIC MAINTAINS HEALTH RELATED QUALITY OF LIFE IN CIRRHOSIS BETTER THAN PLACEBO.
J HEPATOL. 2016; 64: S249-S249.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(16)00262-2
[Poster]
Web of Science
FullText
FullText_MUG
Horvath, A; Leber, B; Schmerboeck, B; Tawdrous, M; Zettel, G; Hartl, A; Madl, T; Stryeck, S; Fuchs, D; Lemesch, S; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Rainer, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V
A multispecies probiotic enhances antimicrobial activity in cirrhosis: A randomized, double blind placebo-controlled study
Zeitschrift für Gastroenterologie . 2016; (5):385-520.-Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 16-18, ; Wien.
[Poster]
Jungst, C; Stadlbauer, V; Reichert, MC; Ofner-Ziegenfuss, L; Voigtlander, T; Spindelboeck, W; Fickert, P; Kirchner, GI; Lammert, F; Lankisch, T; Krawczyk, M
NOD2 confers risk for sclerosing cholangitis in critically ill patients: genetic study in two independent cohorts
HEPATOLOGY. 2016; 63(1 SUPP):191A-192A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA.
[Poster]
Web of Science
Leber, B; Ribitsch, W; Schilcher, G; Obermayer-Pietsch, B; Horvath, A; Schmerbock, B; Tawdrous, M; Stiegler, P; Stadlbauer, V
IS COPEPTIN A PREDICTOR OF MORTALITY IN RENAL DYSFUNCTION?
TRANSPL INT. 2016; 29: 16-16.
[Poster]
Web of Science
Leber, B; Stadlbauer, V; Schmerböck, B; Tawdrous, M; Horvath, A; Blesl, A; Rainer, F; Tripolt, NJ; Sourij, H
Probiotics in Diabesity: A pilot study
1. Biomarker Conference Graz; FEB 11-12, 2016; Graz. 2016.
[Poster]
Leber, B; Stadlbauer, V; Schmerböck, B; Tawdrous, M; Horvath, A; Blesl, A; Rainer, F; Tripolt, NJ; Sourij, H
Modulation of gut microbiota in early sepsis: A pilot study
1. Biomarker Conference Graz; FEB 11-12, 2016; Graz. 2016.
[Poster]
Lindheim, L; Bashir, M; Münzker, J; Trummer, C; Zachhuber, V; Leber, B; Horvath, A; Pieber, TR; Gorkiewicz, G; Stadlbauer, V; Obermayer-Pietsch, B
Alterations in Gut Microbiome Composition and Barrier Function are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome: A Pilot Study
International Human Microbiome Consortium 6th Congress; Nov 9-11, 2016; Houston, TX. 2016.
[Poster]
Lindheim, L; Bashir, M; Münzker, J; Trummer, C; Zachhuber, V; Leber, B; Pieber, TR; Gorkiewicz, G; Stadlbauer, V; Obermayer-Pietsch, B
Charting the gut microbiome in polycystic ovary syndrome (PCOS): A pilot study
6th SRP DIABETES-ENDOMET Joint Retreat; May 12-13, 2016; Stockholm, SWEDEN. 2016.
[Poster]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligo, R; Schicho, R; Heinemann, A; Marsche, G
Plasma Advanced-Oxidized Protein Products Promote Platelet-Endothelial Crosstalk and Endothelial Tissue Factor Expression
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions; MAY 5-7,2016; Nashville, USA. 2016.
[Poster]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligo, R; Schicho, R; Heinemann, A; Marsche, G;
The role of Plasma advanced-oxidized protein products on platelets and platelet-endothelial interactions
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, Austria. 2016.
[Poster]
Pasterk,L; Lemesch,S; Stadlbauer,V; Heinemann, A; Marsche, G
Oxidized plasma albumin promotes platelet-endothelial crosstalk and tissue factor expression
EAS 2016; MAY 29 - JUN 1; Insbruck, AUSTRIA. 2016.
[Poster]
PK Kump, P Wurm, HP Gröchenig, HH Wenzl, w Petritsch, B Halwachs, M wagner, V. Stadlbauer-Köllner, AJ Eherer, KM Hoffmann, A Deutschmann, G Reicht, L Reiter, P Slawitsch, G Gorkiewicz, C Högenauer
Clinical Response to fecal microbiota Transplantation in chronic active ulcerative colitis depends on the taxonomic composition of the donor microbiota.
United European Gastroenterology Journal; 2016:2 (Supplement 1) . 2016; 2: -UEG week; 15.-19.10.2016; Wien.
[Oral Communication]
Schaffellner, S; Stauber, R; Sereinigg, M; Muller, H; Fickert, P; Hogenauer, C; Krumnikl, J; Lackner, C; Stadlbauer, V; Kniepeiss, D
THE DOSE MAKES THE POISON: ACUTE LIVER FAILURE AFTER VITAMIN B3 OVERDOSAGE
TRANSPL INT. .. 2016; 29: 11-11.
[Poster]
Web of Science
Schmerbock, B; Leber, B; Tawdrous, M; Stiegler, P; Stadlbauer, V; Horvath, A
PATIENTS WITH HEPATITIS C-ASSOCIATED CIRRHOSIS HAVE A DEFECTIVE CONGENITAL IMMUNE DEFENCE
TRANSPL INT. 2016; 29: 13-13.
[Poster]
Web of Science
Schmerböck,B; Horvath, A; Tawdrous, M; Leber, B; Stiegler, P; Stadlbauer, K;
Patienten mit Hepatitis C-assoziierter Zirrhose haben eine
gestörte angeborene Immunabwehr
Jahrestagung der österreichischen Gesellschaft für Gastroenterologie und Hepatologie, ÖGGH; JUN 16-18, 2016; Wien. 2016.
[Poster]
Schmerböck,B; Horvath, A; Tawdrous, M; Leber, B; Stiegler, P; Stadlbauer, V;
Patienten mit Hepatitis C-assoziierter Zirrhose haben eine
gestörte angeborene Immunabwehr
Tagung der Österreichischen Gesellschaft für Transplantation, Transfusion und Genetik- Austrotransplant; 19.-21.10.2016; Schladming, AUSTRIA. 2016.
[Poster]
Stadbauer, V
Pro- und Präbiotika
2. ÖÄK-Diplomlehrgang Ernährungsmedizin in Graz: Seminar 2: Ernährungsphysiologie - Grundlagen der Ernährungslehre; 2016.
[Oral Communication]
Stadlbauer, V
Organspende und digitale Medien – Chance oder Spielerei?
Jahrestagung Austrotransplant; OCT 17-19, 2016; Schladming. 2016.
[Oral Communication]
Stadlbauer, V
Das Mikrobiom
Fortbildung im Bezirk; APR 27, 2016; 2016.
[Oral Communication]
Stadlbauer, V
Mikrobiom
ÖGAM; MAR 14, 2016; Graz. 2016.
[Oral Communication]
Stadlbauer, V
Mikrobiom und Leberfunktion
; MAR 8, 2016; Graz. 2016.
[Oral Communication]
Stadlbauer, V
Was gibt es Neues zu Mikrobiom und Leber
Fachakademie der Ärzte; SEP 16, 2016; Wien. 2016.
[Oral Communication]
Stadlbauer, V
App Leitfaden Organspende
Tag der Organspende; NOV 3, 2016; Graz. 2016.
[Oral Communication]
Stadlbauer, V
Das Darm-Mikrobiom:
mögliche therapeutische Ansätze
Fortbildung LKH Hartberg, Innere Medizin; MAY 11, 2016; Hartberg. 2016.
[Oral Communication]
Stadlbauer, V
Leberzirrhose: Ein Problem des Darms
3. AGMID Kongress; JUN 5, 2016; Berlin. 2016.
[Oral Communication]
Stadlbauer, V
Darmflora und Probiotika
Wo steht die Forschung?
Was ist relevant für die Praxis?
Fortbildung Barmherzige Brüder Salzburg; JAN 19, 2016; Salzburg. 2016.
[Oral Communication]
Stadlbauer, V.
The gut-liver axis
Microbiome Science Days; OCT 7-8, 2016; Berchtesgaden. 2016.
[Oral Communication]
Stadlbauer, V.
Hepatorenales Syndrom, Hepatische Enzephalopathie
wrap-up EASL; APR 23, 2016; Wien. 2016.
[Oral Communication]
Stadlbauer, V.
Mikrobiom
Fortbildungsveranstaltung KH der Elisabethen Linz; APR 4, 2016; Linz. 2016.
[Oral Communication]
Stadlbauer, V.
Darm-Leber-Hirn-Achse
Die Rolle des Mikrobioms und therapeutische Ansätze
Fortbildung Ärztekammer Wien; SEP 28, 2016; Wien. 2016.
[Oral Communication]
Stadlbauer, V.
Leberzirrhose: ein Problem des Darms?
Jahrestagung der deutschen Gesellschaft für Innere Medizin; APR 11, 2016; Mannheim. 2016.
[Oral Communication]
Stadlbauer, V.
Das Mikrobiom
Darmbakterien und ihre zentrale Rolle in der menschlichen Gesundheit
Mikrobiom - Darmbakterien als Schlüssel zur Gesundheit; SEP 30, 2016; Linz. 2016.
[Oral Communication]
Stadlbauer, V; Fickert, P; Zink, M
DEVELOPMENT OF AN APP TO FACILITATE AND IMPROVE THE ORGANIZATIONAL PROCESS IN ORGAN DONATION
TRANSPL INT. .. 2016; 29: 10-10.
[Poster]
Web of Science
Stadlbauer-Köllner, V
Prä- und Probiotika
Gastro-Seminar; JAN 22, 2016; Graz. 2016.
[Oral Communication]
Stadlbauer-Köllner, V
Mikrobiom
47. Kongress für Allgemeinmedizin; NOV 25, 2016; Graz. 2016.
[Oral Communication]
Stadlbauer-Köllner, V
Neues zum Mikrobiom
Wissenschaft trifft Praxis 2016; DEC 2, 2016; Graz. 2016.
[Oral Communication]
Stadlbauer-Köllner, V
Probiotika in Prophylaxe und Therapie
12. Internationales Symposium der OePROM; DEC 3, 2016; Wien. 2016.
[Oral Communication]
Stadlbauer-Köllner, V
Leberzirrhose - ein Problem des Darms?
Menopause; Dec 8, 2016; Wien. 2016.
[Oral Communication]
Stadlbauer-Köllner, V
Macht das Microbiom die Leber krank?
Was tut sich in der Darmflora – Teil 3; NOV 22, 2016; Graz. 2016.
[Oral Communication]
Stadlbauer-Köllner, V.
Der Stationäre Patient auf der Warteliste
LTX-Kurs Innsbruck; JAN 29, 2016; Innsbruck. 2016.
[Oral Communication]
Stadlbauer-Köllner, V.
Leitfaden Organspende
ÖBIG Klausurtagung; NOV 24, 2016; Wien. 2016.
[Keynote lecture]
Stauber, R; Haas, J; Wagner, D; Kniepeiss, D; Stadlbauer, V; Ferlitsch, A; Roedl, K; Fuhrmann, V
THE ALBICC MODEL: A NEW PROGNOSTIC TOOL FOR PREDICTION OF SHORT-TERM SURVIVAL IN PATIENTS WITH END-STAGE LIVER DISEASE
TRANSPL INT. .. 2016; 29: 12-13.
[Poster]
Web of Science
Stauber, RE; Haas, J; Wagner, D; Kniepeiss, D; Stadlbauer, V; Ferlitsch, A; Fuhrmann, V;
THE ALBICC MODEL: A NEW PROGNOSTIC TOOL FOR PREDICTION OF SHORT-TERM SURVIVAL IN PATIENTS WITH END-STAGE LIVER DISEASE.
J HEPATOL. 2016; 64: S284-S284.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(16)00346-9
[Poster]
Web of Science
FullText
FullText_MUG
Tawdrous, M; Horvath, A; Schmerbock, B; Leber, B; Spindelbock, W; Fauler, G; Stojakovic, T; Stiegler, P; Stadlbauer, V
GUT PERMEABILITY AND NEUTROPHIL FUNCTION IN SECONDARY SCLEROSING CHOLANGITIS OF CRITICALLY ILL PATIENTS
TRANSPL INT. 2016; 29: 20-20.
[Poster]
Web of Science
Trieb, M; Horvath, A; Birner-Gruenberger, R; Stadlbauer, V; Pasterk, L; Heinemann, A; Marsche, G
HDL Functionality And Liver Disease Mortality – A Causal Role For HDL In Cirrhosis?
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Holzer, M; Marsche, G
Liver disease alters HDL composition and function
EAS Congress 2016; MAY 29 - JUN 1; Insbruck, AUSTRIA. 2016.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Taschler, U; Curcic, S; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Liver Disease Alters HDL Composition, Metabolism and Function
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions; MAY 5-7, 2016; Nashville, USA. 2016.
[Poster]
Trieb, M; Stadlbauer, V; Birner-Gruenberger, R; Marsche, G
LIVER DISEASE ALTERS HIGH-DENSITY LIPOPROTEIN COMPOSITION, METABOLISM AND FUNCTION
ATHEROSCLEROSIS. 2016; 252: E225-E225.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA.
Doi: 10.1016/j.atherosclerosis.2016.07.199
[Oral Communication]
Web of Science
FullText
FullText_MUG
Tripolt, N; Aberer, F; Schreiber, F; Url, J; Eherer, A; Sourij, C; Obermayer, A; Stadlbauer, V; Hogenauer, C; Sourij, H
Pilot Study for the Monitoring of Short-Term Metabolic Effects after Implantation of a Duodeno-Jejunal Bypass Liner (EndoBarrier (R)) in adipose Patients with Diabetes Mellitus Type 2
WIEN KLIN WOCHENSCHR. 2016; 128: S421-S422.
[Oral Communication]
Web of Science
Barbara Obermayer-Pietsch, Matthias Ulbing, Alexander Kirsch, Schweighofer Natascha, Bettina Leber, Sandra Lemesch, Alexander Rosenkranz, Helmut Müller, Kathrin Eller, Vanessa Stadlbauer
Specific microRNA signatures in CKD patients focusing on the risks of calcifications and ROD
ASBMR Abstract Book. 2015; -ASBMR 2015 Annual Meeting; OCT 9-12, 2015; Seattle, Washington, USA.
[Poster]
Horvath, A; Leber, B; Krones, E; Zollner, G; Durchschein, F; Spindelboeck, W; Lemesch, S; Douschan, P; Fauler, G; Stojakovic, T; Fickert, P; Stauber, R; Stiegler, P; Stadlbauer, V
SERUM BILE ACIDS IN CIRRHOSIS DEPEND ON AETIOLOGY.
J HEPATOL. 2015; 62(S2):S344-S344.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(15)30336-6
[Poster]
Web of Science
FullText
FullText_MUG
Horvath, A; Leber, B; Krones, E; Zollner, G; Fickert, P; Stauber, RE; Lemesch, S; Spindelboeck, W; Durchschein, F; Douschan, P; Stiegler, P; Stojakovic, T; Fauler, G; Stadlbauer, V
Serum bile acids in cirrhosis depend on aetiology.
Z Gastroenterol. 2015; 53(5):512-512.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA.
[Poster]
Horvath, A; Leber, B; Schmerböck, B; Stadlbauer, V;
Endotoxinmessung bei Leberzirrhose: Ein Methodenvergleich.
Zeitschrift für Gastroenterologie . 2015; 53(5):-48. Jahrestagung und 26. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18–20, 2015 ; Salzburg, AUSTRIA.
[Poster]
Horvath, A; Leber, B; Schmerboeck, B; Tawdrous, M; Hartl, A; Lemesch, S; Fickert, P; Stauber, RE; Stiegler, P; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Spindelboeck, W; Oettl, K; Payerl, D; Stadlbauer, V
Probiotic supplementation improves liver function but fails to restore neutrophil phagocytosis in stable cirrhosis. A randomized, double-blind, placebo-controlled study
HEPATOLOGY. . 2015; 62: 1216A-1216A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA.
[Oral Communication]
Web of Science
Horvath, A; Schmerböck, B; Leber, B; Stadlbauer, V;
ENDOTOXINMESSUNG BEI LEBERZIRRHOSE- EIN METHODENVERGLEICH
Österreichische Gesellschaft für Gastroenterologie und Hepatologie- ÖGGH; JUN 18-20,2015; Salzburg. 2015.
[Poster]
FullText
Kienbacher, C; Dolak, W; Traussnigg, S; Steindl-Munda, P; Oettl, K; Stadlbauer, V; Knapp, S; Vogelsang, H; Trauner, M
METABOLIC DISTURBANCES AFTER FRUCTOSE OVERCONSUMPTION ARE NOT LINKED TO INTESTINAL PERMEABILITY IN HEALTHY YOUNG VOLUNTEERS
J HEPATOL. 2015; 62: S719-S719.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(15)31193-4
[Poster]
Web of Science
FullText
FullText_MUG
Leber, B; Stadlbauer, V; Lemesch, S; Trajanoski, S; Bashir, M; Sinnitsch, A; Horvath, A; Tawdrous, M; Stojakovic, T; Gauler, G; Fickert, P; Högenauer, C; Klymiuk, I; Stiegler, P; Lamprecht, M; Pieber; TR, Tripolt, NJ, Sourij, H
Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome
Zeitschrift für Gastroenterologie. 2015; -48. Jahrestagung der ÖGGH; JUN 19-20; Salzburg, Austria.
[Poster]
Lemesch, S; Leber, B; Schilcher, G; Ribitsch, W; Spindelböck, W; Hafner-Gießauf, H; Payerl, D; Rosenkranz, A; Öttl, K; Stadlbauer, V;
Oxidative stress in renal insufficiency: focus on acute renal failure and kidney graft patients
DK MOLIN. 2015; -Mini-Symposium “The immune system in kidney and liver disease”; 21 Apr, 2015; Graz.
[Poster]
Lemesch, S; Spindelböck, W; Leber, B; Payerl, D; Stauber, R; Öttl, K; Stadlbauer, V;
Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF
48. Jahrestagung. 2015; -ÖGGH; 19-20 Jun, 2015; Salzburg.
[Poster]
Lemesch, S; Spindelboeck, W; Leber, B; Payerl, D; Stauber, R; Oettl, K; Stadlbauer, V;
Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF.
Z Gastroenterol. 2015; 53(05):77-77.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA.
[Poster]
FullText
Matthias Ulbing, Alexander Kirsch, Natascha Schweighofer, Bettina Leber, Sandra Lemesch, Alexander Rosenkranz, Helmut Müller, Kathrin Eller, Vanessa Stadlbauer, Barbara Obermayer-Pietsch
Specific MicroRNAs as Biomarkers in CKD Patients at
High Risk for Calcifications and ROD?
IBMS BoneKEy 13, Article number: 673 (2015)
Poster Presentations. 2015; -4th Joint Meeting of ECTS and IBMS; APR 25-28, 2015; Rotterdam, The Netherlands.
[Poster]
Matthias Ulbing, Daniela Hofer, Alexander Kirsch, Natascha Schweighofer, Bettina leber, Sandra lemesch, Alexander Rosenkranz, Helmut Müller, Kathrin Eller, Vanessa Stadlbauer, Barbara Obermayer-Pietsch
MicroRNAs: Biomarker für gefäßkalzifizierung bei chronischer Niereninsuffzienz?
Osteologie . 2015; 24: -Osteologie 2015; MAR 12-14, 2015; Berlin, GERMANY.
[Poster]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligoi, R; Schicho,R; Heinemann, A; Marsche,G
Plasma advanced-oxidized protein products promote platelet-endothelial crosstalk and endothelial tissue factor expression
Mini-Symposium "The immune system in kidney and liver disease"; APR 21, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligoi, R; Schicho,R; Heinemann, A; Marsche,G,
Plasma advanced-oxidized protein products promote platelet-endothelial crosstalk and endothelial tissue factor expression
INFLAME - Symposium on Inflammation & Immunology; SEP 13-15, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Pasterk, L; Lemesch, S; Trieb, M; Curcic, S; Appierto, M; Stadlbauer, V; Schuligoi, R; Heinemann, A; Marsche, G
Advanced-oxidized protein products activate platelets through CD36, promoting platelet-endothelial crosstalk and tissue factor expression
AAS meeting ; MAI 8-9, 2015; St. Gilgen, AUSTRIA. 2015.
[Poster]
Sereinigg, M; Stadlbauer, V; Seifert-Held, T; Iberer, F; Stiegler, P
A 10 Min "No-Touch" Time Is It Enough in DCD? A DCD Animal Study
AM J TRANSPLANT. 2015; 15: -American Transplant Congress; MAY 02-06, 2015; Philadelphia, PA.
[Oral Communication]
Web of Science
Stadlbauer, V
Sonstige Komplikationen der Leberzirrhose
10. Post AASLD Symposium; JAN 9.10, 2015; Linz. 2015.
[Oral Communication]
Stadlbauer, V
Probiotika - heiß diskutiert.
Fortbildung im Bezirk; JUL 2, 2015; Schwanberg. 2015.
[Oral Communication]
Stadlbauer, V.
Die Leber auf der Intensivstation - Täter oder Opfer?
Fortbildungsveranstaltung
der Kärntner Abteilungen für Anästhesiologie und Intensivmedizin; Nov 10, 2015; Klagenfurt. 2015.
[Oral Communication]
Stadlbauer, V.
Hepatische Enzephalopathie
48. Jahrestagung der ÖGGH; JUN 18-20, 2015; Salzburg. 2015.
[Oral Communication]
Stadlbauer, V.
The world of liver disease
Minisymposium "The immune System in Kidney and Liver Disease"; APR 21, 2015; Graz, Austria. 2015.
[Oral Communication]
Stadlbauer, V.
Die Behandlung des Zirrhotikers
Allgemeinmedizin Update Refresher ; JUN 9-13, 2015; Wien. 2015.
[Oral Communication]
Stadlbauer, V.
Wichtige Lebererkrankungen – Diagnostik und Therapie
15. Innere Medizin Update - Refresher; JUN 9-13, 2015; Wien. 2015.
[Oral Communication]
Stadlbauer, V.
Probiotika - heiß diskutiert! Einsatzmöglichkeiten evaluiert aus der Forschung, was ist geeignet für die Praxis?
; Jun 1, 2015; Weiz. 2015.
[Oral Communication]
Stadlbauer, V.
Probiotika - heiß diskutiert
Fortbildung im Bezirk; MAR 19, 2015; Unterpremstätten. 2015.
[Poster]
Stadlbauer, V.
Leberzirrhose - ein Problem des Darms?
11. Jahrestagung der österreichischen Gesellschaft für probiotische Medizin; DEZ 5, 2015; Wien. 2015.
[Oral Communication]
Stadlbauer, V.
Das Mikrobiom - Auswirkungen auf den Stoffwechsel und Therapieansätze
Fortbildung im Bezirk; MAR 19, 2015; Unterpremstätten. 2015.
[Oral Communication]
Stadlbauer, V.
Das Mikrobiom - Darmbakterien und ihre zentrale Rolle in der menschlichen Gesundheit. Wo steht die Forschung, was ist relevant für die Praxis?
Fortbildung im Bezirk; JUN 16, 2015; Knittelfeld. 2015.
[Oral Communication]
Stadlbauer, V.
Dysbiosis in alcoholic fatty liver disease
EASL Monothematic conference Microbiota, Metabolism and NAFLD; FEB 26-28, 2015; Innsbruck. 2015.
[Oral Communication]
Stadlbauer, V.
Probiotika-heiß diskutiert!
Wo steht die Forschung? Was ist geeignet für die klinische Praxis
Mikrobiom Update 2015; NOV 10, 2015; Klagenfurt. 2015.
[Oral Communication]
Stadlbauer, V.
Die Behandlung des Zirrhotikers
ALlgemeinmedizin Update Refresher; Nov 11, 2015; Wien. 2015.
[Oral Communication]
Stauber, R; Stadlbauer, V; Spindelboeck, W; Rainer, F; Posch, A; Streit, A; Jakoby, E; Kniepeiss, D; Muller, H
INTERFERON-FREE ANTI-HCV THERAPY AFTER ORGAN TRANSPLANTATION
TRANSPL INT. 2015; 28: 11-11.
[Oral Communication]
Web of Science
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, R; Holzer, M; Pasterk, L; Taschler, U; Heinemann, A; Marsche, G
Cirrhosis alters HDL metabolism and function
INFLAME - Symposium on Inflammation & Immunology; SEP 13-15, 2015; Graz. 2015.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G
Metrics of HDL functions are markedly impaired in cirrhosis
22nd Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 8-9, 2015; St. Gilgen/Wolfgangsee, AUSTRIA. 2015.
[Oral Communication]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Holzer, M; Marsche, G
Liver cirrhosis, high–density lipoproteins and anti-inflammatory and endothelial regenerative activities of serum
Mini-Symposium "The immune system in kidney and liver disease"; APR 21, 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Douschan, P; Kovacs, G; Stadlbauer-Koellner, V; Spindelboeck, W; Krones, E; Durchschein, F; Zollner, G; Rainer, F; Foris, V; Fickert, P; Olschewski, H; Stauber, RE
CARDIOPULMONARY EXERCISE TESTING IN PATIENTS WITH PORTAL HYPERTENSION AND EARLY STAGE LIVER DISEASE.
Journal of Hepatology. 2014; 60(1):236-236.-International Liver Congress / 49th Annual meeting of the European Association for the Study of the Liver ; April 9 - 13, 2014; London, ENGLAND.
[Poster]
Douschan, P; Kovacs, G; Stadlbauer-Koellner, V; Spindelboeck, W; Krones, E; Durchschein, F; Zollner, G; Rainer, F; Foris, V; Wagner, M; Fickert, P; Olschewski, H; Stauber, RE
Cardiopulmonary response to exercise in patients with portal hypertension and early stages of liver cirrhosis.
Z Gastroenterol. 2014; 52 - P66: -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); 12. – 14. Juni, 2014; Villach, AUSTRIA.
[Poster]
Hofer,P; Stadlbauer, V; Lang-Olip, I; Mayrhauser, U;
Koestenbauer, S; Leber, B; Tawdrous, M; Moche, M;
Sereinigg, M; Seider, D; Iberer, F; Wiederstein-Grasser, I;
Portugaller, H; Stiegler, P;
Immunohistochemical and Radiological Characterization of Wound
Healing after Radiofrequency Ablation (RFA): A Study in Healthy
Pigs (
Surgery meets Biomedical Engineering; NOV 13-15, 2015; Wagrain, AUSTRIA. 2014.
[Oral Communication]
Horvath, A; Leber, B; Lemesch, S; Spindelboeck, W; Stauber, RE; Stiegler, P; Stadlbauer, V;
Chronic Hepatitis C infection diminishes neutrophil function
Z Gastroenterol 2014; 52 - P73. 2014; -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 12-14, 2014; Villach, Austria.
[Poster]
Horvath, A; Leber, B; Lemesch, S; Stiegler, P; Stauber, RE; Fickert, P; Zollner, G; Spindelboeck, W; Durchschein, F; Krones, E; Douschan, P; Stadlbauer, V
Neutrophil dysfunction in liver cirrhosis despite sufficient opsonisation
Z Gastroenterol 2014; 52 - P62. 2014; -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 12-14, 2014; Villach, Austria.
[Poster]
Horvath, A; Leber, B; Lemesch, S; Suppan, O; Yuksel, O; Sherzay, K; Zettel, G; Tawdrous, M; Spindelboeck, W; Durchschein, F; Krones, E; Douschan, P; Zollner, G; Fickert, P; Stauber, R; Stiegler, P; Stadlbauer, V
LISTING FOR LIVER TRANSPLANT: NO IMPACT ON THE QUALITY OF LIFE
TRANSPL INT. 2014; 27: 20-21.
[Poster]
Web of Science
Horvath, A; Leber, B; Spidelboeck,W; Stiegler, P; Stauber, RE; Lemesch, S; Douschan, P; Durchschein,F; Fickert, P; Krones, E; Zollner, G; Stadlbauer, V
THE NEUTROPHIL CAUGHT BETWEEN CIRRHOSIS, GUT PERMEABILITY AND VIRAL HEPATITIS C.
UEG Journal; October 2014; 2 (1 suppl)
22nd United European Gastroenterology Week Vienna, Austria, October 18-22, 2014 Abstract Issue. 2014; -United European Gastroenterology Week; OCT 18-22, 2014; Vienna, Austria.
[Poster]
Horvath, A; Leber, B; Spindelböck, W; Stiegler, P; Stauber, RE; Lemesch, S; Douschan, P; Durchschein, F; Fickert, P; Krones, E; Zollner, G; Stadlbauer V;
THE NEUTROPHIL CAUGHT BETWEEN CIRRHOSIS, GUT PERMEABILITY AND VIRAL HEPATITIS C.
ZMF 10th Anniversary; JUL 17-18, 2014; Graz, Austria. 2014.
[Oral Communication]
Krones, E; Zitta, S; Neunherz, S; Artinger, K; Stojakovic, T; Reibnegger, G; Durchschein, F; Buchgrabner, J; Stadlbauer, V; Fickert, P; Rosenkranz, AR
Chronic Kidney Disease Epidemiology Collaboration Equation combining Creatinine and Cystatin C is superior to other Creatine- and Cystatin C-based Equations in Assessing Renal Function in Patients with Cirrhosis.
HEPATOLOGY. 2014; 60: 325A-325A.-65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 07-11, 2014; Boston, USA.
[Poster]
Web of Science
Krones, E; Zitta, S; Neunherz, S; Artinger, K; Stojakovic, T; Reibnegger, G; Durchschein, F; Stadlbauer-Kollner, V; Fickert, P; Rosenkranz, A
The CKD-EPI Formula, Creatinine and Cystatin C used in combination, is superior to another Creatinine- and Cystatin C based Formulas for Renal Function Determination in Cirrhosis.
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):577-577.-45. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 25-27, 2014; Salzburg, AUSTRIA.
[Poster]
Web of Science
Leber, B; Horvath, A; Lemesch, S; Spindelboeck, W; Stiegler, P; Stauber, RE; Stadlbauer, V
Triple Therapy for chronic Hepatitis C infection: the neutrophil is not amused.
Z Gastroenterol 2014; 52 - V03. 2014; -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; JUN 12-14, 2014; Villach, AUSTRIA.
[Oral Communication]
Leber, B; Horvath, A; Lemesch, S; Stiegler, P; Stadlbauer, V; Spindelboeck, W
Triple Therapy for Chronic Hepaitits C infection: The Neutrophil is not amused
Journal of Hepatology, Supplement. 2014; 60(1):119--EASL; APR 9-13, 2014; London, United Kingdom.
[Poster]
Leber, B; Tripolt, NJ; Trajanoski, S; Hoegenauer, C; Klymiuk, I; Sourij, H; Stadlbauer, V
Supplementation with a probiotic milk drink does not alter gut microbiota composition in patients with metabolic syndrome.
UEG Journal; October 2014; 2 (1 suppl) 22nd United European Gastroenterology Week Vienna, Austria, October 18-22, 2014 Abstract Issue.. 2014; -UEGW; OCT 18-22, 2014; Vienna, Austria.
[Poster]
Lemesch , S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Hafner-Gießauf, H; Spindelboeck, W; Pasterk, L; Marsche, G; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
Eine Nierentransplantation kann sich positiv auf die Funktion neutrophiler Granulozyten und den oxidativen Stress auswirken.
Transplant International, John Wiley & Sons, Ltd. 2014; 27(s4):1-27.-Austrotransplant; 15-17 Okt, 2014; Bad Ischl, Austria.
[Oral Communication]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Hafner-Giessauf, H; Spindelboeck, W; Pasterk, L; Marsche, G; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
KIDNEY TRANSPLANT MAY BE POSITIVE ON THE FUNCTION NEUTROPHILER GRANULOCYTES AND THE OXIDATIVE STRESS EFFECT
TRANSPL INT. 2014; 27: 6-6.-Austrotranspalnt; 15-17 Okt, 2014; Bad Ischl, Austria.
[Oral Communication]
Web of Science
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, AR; Stadlbauer, V
Sevelamer possibly influences neutrophil function in dialysis patients via endotoxin binding.
Nephrol. Dial. Transplant (ndt). 2014; 29(suppl3):iii501-iii515.-ERA-EDTA Congress; 31-3 Mai/Juni, 2014; Amsterdam, NETHERLANDS.
[Poster]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; A.R. Rosenkranz,AR; Stadlbauer, V
THE LEAKY GUT IN PATIENTS WITH RENAL DISEASE
Abstract. 2014; -ERA-EDTA Congress; SEP 6-9, 2014; Berlin, GERMANY.
[Poster]
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
Positiver Effekt der Nierentransplantation auf die Funktion neutrophiler Granulozyten und oxidativen Stress.
Austian Journal of Hypertension. 2014; 18(3):110-128.-Jahrestagung Nephrologie &
Hypertensiologie; 18-22 Sep, 2014; Baden, AUstria.
[Poster]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
The leaky gut in patients with chronic kidney disease
UEG Journal. 2014; 2(suppl1):A132-A605.-UEGW; 18-22 Okt, 2014; Vienna, Austria.
[Poster]
FullText
Lemesch, S; Leber, B; Ribitsch, W; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; Rosenkranz, A; Stadlbauer, V
The leaky gut in patients with renal disease
Abstract-USB Stick. 2014; -DGfN; 6-9 Sep, 2014; Berlin, Germany.
[Poster]
Lemesch ,S; Ribitsch, W; Leber, B; Schilcher, G; Horvath, A; Pasterk, L; Marsche, G; Spindelboeck, W; Hafner-Giessauf, H; Zettel, G; Tawdrous, M; A.R. Rosenkranz, AR; Stadlbauer, V;
POSTIVER EFFEKT DER NIERENTRANSPLANTATION AUF DIE FUNKTION NEUTROPHILER GRANULOZYTEN.
Jahrestagung Nephrologie und Hypertensiologie; 18.-20. Sept; Baden, AUSTRIA. 2014.
[Poster]
Sereinigg, M; Puntschart, A; Seifert-Held, T; Wiederstein-Grasser, I; Leber, B; Stadelmeyer, E; Dandachi, N; Stadlbauer-K, V; Iberer, F; Stiegler, P
Oxidative Stress and Apoptosis in a Pig Model of Brain Death (BD) and Living Donation (LD).
AM J TRANSPLANT. 2014; 14: 372-372.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
[Poster]
Web of Science
Sereinigg, M; Puntschart, A; Seifert-Held, T; Wiederstein-Grasser, I; Leber, B; Stadelmeyer, E; Dandachi, N; Stadlbauer-K, V; Iberer, F; Stiegler, P;
Oxidative Stress and Apoptosis in a Pig Model of Brain Death (BD) and Living Donation (LD).
TRANSPLANTATION. 2014; 98: 372-372.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
[Poster]
Web of Science
Stadlbauer, V
Neues von der Darm-Leber Achse
10 Symposium der Österreichischen Gesellschaft für probiotische Medizin; 29.11.2014; Wien. 2014.
[Oral Communication]
Stadlbauer-Köllner, V
"Darmgesundheit" - Mechanismen der Darmbarriere
Mariatroster Forschungsklausurtagung 2014; 30.5.2014; Graz, Austria. 2014.
[Keynote lecture]
Stadlbauer-Köllner, V
Leberversagen und Immunologie: Der Leberpatient verstirbt an der Sepsis
Intensivseminar Steyr; 9.5.2014; Steyr, Austria. 2014.
[Oral Communication]
Stadlbauer-Köllner, V
Darm-Leber Achse
1 Jahrestagung der DeProm; SEP, 27-28, 2014; Berchtesgaden, Deutschland. 2014.
[Oral Communication]
Stauber, R; Stadlbauer, V; Spindelboeck, W; Posch, A; Streit, A; Kniepeiss, D; Iberer, F
FIRST EXPERIENCES WITH SOFOSBUVIR-BASED INTERFERON FREE TREATMENT OF HCV-INFECTION BEFORE OR AFTER LIVER TRANSPLANTATION
TRANSPL INT. 2014; 27: 15-15.
[Oral Communication]
Web of Science
Stiegler, P; Sereinigg, M; Haimel, G; Zeugswetter, F; Dupre, G; Iberer, F; Witter, K; Stadlbauer-Koellner, V
Biocompatibility of Sodium Cellulose Sulfate (SCS) Microencapsulated Porcine Islet Cells in Five Beagle Dogs.
AM J TRANSPLANT. 2014; 14: 419-419.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
[Poster]
Web of Science
Stiegler, P; Sereinigg, M; Haimel, G; Zeugswetter, F; Dupre, G; Iberer, F; Witter, K; Stadlbauer-Koellner, V;
Biocompatibility of Sodium Cellulose Sulfate (SCS) Microencapsulated Porcine Islet Cells in Five Beagle Dogs..
TRANSPLANTATION. 2014; 98: 419-419.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
Doi: 10.1097/00007890-201407151-01388
[Poster]
Web of Science
FullText
FullText_MUG
Stiegler, P; Sereinigg, M; Puntschart, A; Seifert-Held, T; Leber, B; Hallstroem, S; Iberer, F; Stadlbauer-Koellner, V
Influences of the Donor Type On Organ Energy Status: Living Versus Brain Dead Versus DCD
AM J TRANSPLANT. 2014; 14: 377-377.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
[Poster]
Web of Science
Stiegler, P; Sereinigg, M; Puntschart, A; Seifert-Held, T; Leber, B; Hallstroem, S; Iberer, F; Stadlbauer-Koellner, V;
Influences of the Donor Type On Organ Energy Status: Living Versus Brain Dead Versus DCD..
TRANSPLANTATION. 2014; 98: 377-377.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
Doi: 10.1097/00007890-201407151-01231
[Poster]
Web of Science
FullText
FullText_MUG
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Marsche, G
Low HDL levels in cirrhotic patients are linked to severely impaired anti-inflammatory and endothelial regenerative activities of serum
2nd Retreat, Doctoral College-Molecular Fundamentals of Inflammation; OKT 29-30, 2014; Seggau, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath, A; Spindelböck, W; Stadlbauer, V; Stauber, RE; Pasterk, L; Marsche, G
Low HDL levels in cirrhotic patients are linked to severely impaired anti-inflammatory and endothelial regenerative activities of serum
Doctoral Day; DEC 10, 2014; Graz, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath, A; Stadlbauer, V; Pasterk, L; Marsche, G
Liver cirrhosis is associated with reduced anti-inflammatory capacity of serum: Central role of high-density lipoprotein
20th Scientific Symposium of the Austrian Pharmacological Society; SEP 26-27, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Trieb, M; Horvath A; Stadlbauer V; Pasterk L; Marsche G
Liver cirrhosis is associated with reduced anti-inflammatory capacity of serum: Central role of high-density lipoprotein
Gordon Research Seminar; JUNE 14-15, 2014; Waterville Valley, USA. 2014.
[Poster]
Trieb M; Horvath A; Stadlbauer V; Pasterk L; Marsche G
Liver cirrhosis is associated with reduced anti-inflammatory capacity of serum: Central role of high-density lipoprotein
Gordon Research Conference; JUNE 15-20, 2014; Waterville Valley, USA. 2014.
[Poster]
Ulbing, M; Kirsch, A; Schweighofer, N; Leber, B; Lemesch, S; Rosenkranz, A; Eller, K; Müller, H; Stadlbauer, V; Obermayer-Pietsch, B;
MicroRNAs als Biomarker für vaskuläre Kalzifizierung in CKD Patienten
OEGES; Apr 3-4; Wien, Austria. 2014.
[Oral Communication]
Ulbing, M; Kirsch, A; Schweighofer, N; Leber, B; Lemesch, S; Rosenkranz, A; Eller, K; Müller, H; Stadlbauer, V; Obermayer-Pietsch, B;
Micro-RNAs as new putative biomarkers for vascular calcification in CKD patients
Austrian Biomarker Symbosium; Mar 31-Apr 1; Vienna, Austria. 2014.
[Poster]
Ulbing, M; Kirsch, A; Schweighofer, N; Leber, B; Lemesch, S; Rosenkranz, A; Eller, K; Müller, H; Stadlbauer, V; Obermayer-Pietsch, B;
micro-RNA als Neuer Biomarker zur Beobachtung von Vaskulärer Verkalkung bei chronischen nierenerkrankungen
Osteologie; März 13-15, 2014; München, Deutschland. 2014.
[Poster]
Ulbing, M; Kirsch, A; Schweighofer, N; Leber, B; Lemesch, S; Rosenkranz, A; Eller, K; Müller, H; Stadlbauer, V; Obermayer-Pietsch, B;
MicroRNAs as new biomarkers for monitoring of vascular calcification in CKD patients
ECTS; May 17-20, 2014; Prague, Czech Republic. 2014.
[Poster]
A, Horvath; B, Leber; S, Lemesch; P, Stiegler; R, Stauber;
P, Fickert; G, Zollner; W, Spindelboeck; E, Krones;
F, Durchschein; P, Douschan; V, Stadlbauer
INCREASED GUT PERMEABILITY, ELEVATED ENDOTOXIN RELATED PROTEINS AND NEUTROPHIL DYSFUNCTION IN LIVER CIRRHOSIS.
Journal of Hepatology. 2013; 58(S1):S104--48th Annual meeting of the European Association for the Study of the Liver
; 24 April 2013 - 28 April 2013; Amsterdam.
Doi: 10.1016/S0168-8278(13)60246-9
[Poster]
Web of Science
FullText
FullText_MUG
Durchschein, F; Krones, E; Spindelböck, W; Stauber, RE; Lackner, K; Portugaller, H; Stadlbauer-Köllner, V; Fickert, P
Resultate der transarteriellen Chemoembolisation (TACE) bei hepatozellulärem Karzinom (HCC) and der Medizinischen Universität Graz zwischen 2004-2011
Zeitschrift für Gastroenterologie. 2013; 51(05):A8-A8.-ÖGGH Jahrestagung 2013; Jun 13-15, 2013; Graz, AUSTRIA.
[Poster]
Horvath, A; Leber, B; Lemesch, S; Stiegler, P; Stauber, R; Fickert, P; Zollner, G; Spindelböck, W; Krones, E; Durchschein, F; Douschan, P; Stadlbauer-Köllner, V
Increased gut permeability, elevated endotoxin related products and neutrophil dysfunction in liver cirrhosis
Z Gastroenterol 2013; 51 - A60. 2013; 51: A60--46. Jahrestagung und 24. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); Jun 13-15, 2013; Graz.
[Oral Communication]
FullText
Leber, B; Tripolt, N; Horvath, A; Lemesch, S; Stojakovic, T; Fauler, G; Stauber, R; Fickert, P; Sourji, H; Stadlbauer-Köllner, V
Gut permeability and serum bile acids in metabolic syndrome
Z Gastroenterol 2013; 51 - A59. 2013; 51(5):A59-501.-46. Jahrestagung und 24. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 13-15, 2013; Graz, AUSTRIA.
[Poster]
FullText
Leber, B; Tripolt, N; Lemesch, S; Horvath, A; Stojakovic, T;
Fauler, G; Stauber, R; Fickert, P; Sourij, H; Stadlbauer, V
INCREASED GUT PERMEABILITY IN METABOLIC SYNDROME
IS NOT ASSOCIATED WITH CHANGES IN BILE ACID PROFILE.
J HEPATOL. 2013; 58(S1):S549-S550.-48th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 24-28, 2013; Amsterdam, THE NETHERLANDS.
Doi: 10.1016/S0168-8278(13)61366-5
[Poster]
Web of Science
FullText
FullText_MUG
Masser, T; Krones, E; Högenauer, C; Wenzl, HH; Stauber, R; Putz-Bankuti, C; Fickert, P; Zollner, G; Durchschein, F; Stadlbauer-Köllner, V; Spindelböck, W; Petritsch, P; Kump, P
Appendektomie und klinischer Verlauf bei Patienten mit Colitis ulcerosa
ÖGGH Jahrestagung; JUN 13-15, 2013; Graz, AUSTRIA. 2013.
[Poster]
Ribitsch, W; Schilcher, G; Horina, J; Stadlbauer, V; Rosenkranz, A; Schneditz, D
No discrepancy between relative plasma volume change and absolute plasma volume during ultrafiltration and hemodialysis.
J Am Soc Nephrol. 2013; 24: 589A-589A.-Kidney Week 2013; NOV 5-10, 2013; Atlanta, GEORGIA.
[Poster]
FullText
Ribitsch, W; Schreiner, PJ; Uhlmann, M; Schilcher, G; Stadlbauer, V; Horina, JH; Rosenkranz, AR; Schneditz, D;
Splanchnic ischemia is unlikely to occur with moderate ultrafiltration during hemodialysis.
NEPHROL DIALYSIS TRANSPLANT. Nephrol. Dial. Transplant. 2013; 28(suppl1):250-250.-50th European-Renal-Association - European-Dialysis-and-Transplant-Association Congress; MAY 18-21, 2013; Istanbul, TURKEY.
[Poster]
Web of Science
Ribitsch, W; Schreiner, PJ; Uhlmann, M; Schilcher, G; Stadlbauer-Köllner, V; Horina, JH; Rosenkranz, AR; Schneditz, D
Einfluß der Ultrafiltration auf die Splanchnikusperfusion während der Hämodialyse.
Abstract-USB-Stick, FV 39. 2013; -Kongress für Nephrologie; OCT 5-8, 2013; Berlin, GERMANY.
[Oral Communication]
Schaffellner, S; Wagner, D; Stiegler, P; Sereinigg, M; Kniepeiss, D; Jakoby, E; Stadlbauer-Köllner, V; Iberer, F
Late Everolimus induced pneumonitis, 4 years after introduction in a liver transplant recipient.
Austrotransplant 2014; 2013.
[Poster]
Sereinigg, M; Puntschart, A; Stadlbauer, V; Iberer, F; Leber, B; Tscheliessnigg, KH; Jürgens, G; Seifert-Held, T; Hallström, S; Stiegler, P
Energy Status of Pig Donor Organs after Ischemia is independent of Donor Type.
American Journal of Transplantation. 2013; 13(5):446-446.-American Transplant Congress; May 18 - 22, 2013; Seattle, USA.
[Poster]
Web of Science
Stadlbauer, V; Steiner, P; Schweiger, M; Sereinigg, M; Tscheliessnigg, K; Freidl, W; Stiegler, P
KNOWLEDGE AND ATTITUDE OF HEALTH CARE PROFESSIONALS, STUDENTS AND PATIENTS TOWARDS THE AUSTRIAN ORGAN DONATION LAW
TRANSPL INT. . 2013; 26: 191-191.
[Poster]
Web of Science
Stiegler, P; Hackl, F; Schaffellner, S; Iberer, F; Stadlbauer-Kollner, V; Sereinigg, M
HYPERBARIC OXYGENATION OF UW SOLUTION POSITIVELY IMPACTS ON THE ENERGY STATE OF PORCINE PANCREATIC TISSUE
TRANSPL INT. . 2013; 26: 158-159.
[Poster]
Web of Science
Stiegler, P; Hackl, F; Sereinigg, M; Schaffellner, S; Matzi, V; Smolle-Juttner, FM; Tscheliesnigg, K; Lackner, C; Iberer, F; Jurgens, G; Hallstrom, S; Stadlbauer-Kollner, V
Hyperbaric Oxygenation of UW Solution Positively Impacts on The Energy State of Porcine Pancreatic Tissue
TRANSPLANTATION. 2013; 96(6):S147-S147.-14th World Congress of the International-Pancreas-and-Islet-Transplant-Association (IPITA); SEP 24-27, 2013; Monterey, CA.
[Keynote lecture]
Web of Science
Stiegler, P; Haimel, G; Asslaber, M; Iberer, F; Zeugswetter, F; Schaffellner, S; Stadlbauer-Kollner, V; Tscheliessnigg, K; Dupre, G
Different Implantation Sites of Sodium Cellulose Sulfate Microencapsulated Porcine Islet Cells in Five Beagle Dogs
TRANSPLANTATION. 2013; 96(6):S151-S151.-14th World Congress of the International-Pancreas-and-Islet-Transplant-Association (IPITA); SEP 24-27, 2013; Monterey, CA.
[Poster]
Web of Science
Stiegler, P; Sereinigg, M; Puntschart, A; Bradatsch, A; Stanzer, S; Stadlmeyer, E; Dandachi, N; Leber, B; Wiederstein-Grasser, I; Iberer, F; Tscheliessnigg, KH; Stadlbauer, V
Characterization of Different Gene Families Encoding for Pro-Apoptotic and Anti-Apoptotic as well as Genes Encoding for Oxidative Stress induced Cell Damage in Organ Transplantation: An Animal Study.
American Journal of Transplantation; Supplement 5. 2013; 13(5):400-400.-American Transplant Congress; May 18 - 22, 2013; Seattle, USA.
[Poster]
Web of Science
Stiegler, P; Sereinigg, M; Seifert-Held, T; Wiederstein-Grasser, I; Leber, B; Iberer, F; Stadelmeyer, E; Dandachi, N; Stadlbauer-Kollner, V
OXIDATIVE STRESS AND APOPTOSIS IN A PIG MODEL OF BRAIN DEATH (BD) AND LIVING DONATION (LD)
TRANSPL INT. . 2013; 26: 222-223.
[Poster]
Web of Science
Trieb, M; Horvath, A; Stadlbauer-Köllner, V; Pasterk, L; Holzer, M; Marsche, G
The anti-inflammatory capacity of serum is severely impaired in patients with liver disease and causally linked to a defective HDL metabolism.
Doctoral Day; DEZ 9, 2013; Graz, AUSTRIA. 2013.
[Poster]
Trieb, M; Horvath, A; Stadlbauer-Köllner, V; Pasterk, L; Holzer, M; Marsche, G
The anti-inflammatory capacity of serum is severely impaired in patients with liver disease and causally linked to a defective HDL metabolism.
1st Retreat, Doctoral College-Molecular Fundamentals of Inflammation; NOV 6-7, 2013; Seggau, AUSTRIA. 2013.
[Oral Communication]
Tscheliessnigg, K; Stiegler, P; Haimel, G; Dupre, G; Zeugswetter, F; Stadlbauer-Kollner, V; Sereinigg, M
DIFFERENT IMPLANTATION SITES OF SODIUM CELLULOSE SULFATE MICROENCAPSULATED PORCINE ISLET CELLS IN FIVE BEAGLE DOGS
TRANSPL INT. . 2013; 26: 339-339.
[Poster]
Web of Science
Durchschein F, Stadlbauer V, Fickert P
Sekundär Sklerosierende Cholangitis nach Polytrauma- Ein Fallbericht und Pathogenetisches Modell
WIT; 18.02.2012; Vienna, Austria. 2012.
[Oral Communication]
Durchschein F., Stadlbauer V., Fickert P.
SEKUNDÄR SKLEROSIERENDE CHOLANGITIS NACH POLYTRAUMA EIN FALLBERICHT UND PATHOGENETISCHES MODELL
WIT - Wiener Intensivmedizinische Tage; Feb 15-18, 2012; Venna, AUSTRIA. 2012.
[Poster]
FullText
Jalan, R; Stadlbauer, V; Sen, S; Woodrow, L; Mookerjee, R
Role of Predisposition, Injury, Response and Organ failure (PIRO) in the prognosis of hospitalised cirrhotics with acute deterioration
HEPATOLOGY. 2012; 56: 969A-969A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
[Poster]
Web of Science
Leber B, Tripolt NJ, Blattl D, Eder M, Wascher, TC, Pieber, TR, Stauber, RE, Sourij, H, Oettl, K, Stadlbauer, V
The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: An open label, randomized pilot study
Gut Microbiota in Health and Disease; SEP, 13-15, 2012; Maastricht, THE NETHERLANDS. 2012.
[Poster]
Ribitsch, W; Schreiner, Ph; Uhlmann, M; Schilcher,G; Stadlbauer,V;Rosenkranz,AR; Schneditz,D
Messung des absoluten Plasmavolumens und der Splanchnikusperfusion während der Hämodialyse
Abstracts 2012 zur Jahrestagung der Jahrestagung der Österreichischen Gesellschaft für Nephrologie und der Österreichischen Gesellschaft für Hypertensiologie, NephroScript 9,2012. 2012; -Jahrestagung der Österreichischen Gesellschaft für Nephrologie und der Österreichischen Gesellschaft für Hypertensiologie; Sep 7-8,2012; Graz, Austria.
[Oral Communication]
Sereinigg, M; Stiegler, P; Puntschart, A; Seifert-Held, T; Mayrhauser, U; Leber, B; Tscheliessnigg, KH; Stadlbauer-Köllner, V
Establishing a Non-Heart Beating Donor (NHBD) Model in Pigs.
The Scandinavian Transplantation Society XXVI Congress; May 9 - 11, 2012; Reykjavik, Iceland. 2012.
[Poster]
Stadlbauer, V
Befragung zum Organspendergesetz in Österreich: Unterschiede im Wissensstand und unterschiedliche
Meinungen von Personen im Pflegeberuf oder Studierenden von Gesundheitsstudien im Vergleich zu
Studierenden von anderen Studiengängen und Patienten der Transplantationsambulanz
LTXB-Klausur; 8.11.2012; Wien, AUSTRIA. 2012.
[Keynote lecture]
Stadlbauer, V
Die Leber des Intensivpateinten: Opfer, aber auch Täter?
30. Wiener Intenisvmedizinischen Tage; Feb 15-18, 2012; Wien. 2012.
[Keynote lecture]
Stadlbauer, V
EIn Patient mit hepatischer Enzephalopathie
30. Wiener Intensivmedizinische Tage; Feb 15-18, 2012; Wien. 2012.
[Oral Communication]
Stadlbauer, V
Mikrobiotika beeinflussen?
Blähung, Obstipation und Reizdarm Hilft Ernährungstherapie?; 12.10.2012; Wien. 2012.
[Keynote lecture]
Stadlbauer, V; Steiner, P; Stiegler, P; Tscheliessnigg, KH
Befragung zum Organspendegesetz in Österreich: Unterschiede im Wissensstand und unterschiedliche Meinungen von Personen im Pflegeberuf oder Studierenden von Gesundheitsstudien im Vergleich zu Studienrenden von anderen Studiengängen und Patienten der Transplantationsambulanz.
Supplement 246/12. 2012; 44(246):30-30.-26th Meeting of the Austrian Society of Transplantation, Transfusion and genetics; Oct 17- 19, 2012; Rust, Austria. (ISBN: 1682-8631 )
[Poster]
Stadlbauer, V; Steiner, P; Stiegler, P; Tscheliessnigg, KH
Befragung zum Organspendergesetz in Österreich: Unterschiede im Wissensstand und unterschiedliche
Meinungen von Personen im Pflegeberuf oder Studierenden von Gesundheitsstudien im Vergleich zu
Studierenden von anderen Studiengängen und Patienten der Transplantationsambulanz.
Supplement European Surgery. 2012; -Austrotransplant; OKT 17-19, 2012; Rust, AUSTRIA.
[Oral Communication]
Stadlbauer,V; Leber, B; Tripolt, NJ, Balttl, D., Eder, M., Pieber, TR:, Wascher, TC; Stauber, RE; Oettl, K; Sourji, H.
Increased Gut Permeability in Patients With Metabolic Syndrome
www.ddw.org. 2012; -DDW; May 18-24, 2012; San Diego.
[Poster]
Stauber, RE; Spindelboeck, W; Birner-Gruenberger, R; Putz-Bankuti, C; Stadlbauer, V; Lackner, C; Oettl, K
Human nonmercaptalbumin-2 (HNA2): a novel prognostic marker in chronic liver failure
HEPATOLOGY. 2012; 56: 975A-975A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
[Poster]
Web of Science
Stiegler, P; Sereinigg, M; Curcic, P; Puntschart, A; Bradatsch, A; Seifert-Held, T; Mayrhauser, U; Leber, B; Hallström, S; Tscheliessnigg, KH; Stadlbauer-Köllner V
Influences of the donot type on organ energy status: Living versus brain dead versus non-heart beating donor.
The Scandinavian Transplantation Society XXVI Congress; May 9 - 11, 2012; Reykjavik, Iceland. 2012.
[Poster]
Stiegler, P; Sereinigg, M; Mayrhauser, U; Leber, B; Tscheliessnigg, KH; Stadlbauer-Köllner, V; Stanzer, S; Puntschart, A; Öttl, K
Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donors.
The Scandinavian Transplantation Society XXVI Congress; May 9 - 11, 2012; Reykjavik, Iceland. 2012.
[Poster]
Stiegler, P; Sereinigg, M; Puntschart, A; Bradatsch, A; Seifert-Held, T; Stadlbauer-Köllner, V; Tscheliessnigg, KH
Establishing a brain death donor model in pigs.
The Scandinavian Transplantation Society XXVI Congress; May 9 - 11, 2012; Reykjavik, Iceland. 2012.
[Poster]
Stiegler, P; Sereinigg, M; Puntschart, A; Seifert-Held, T; Mayrhauser, U; Leber, B; Stadlbauer-Köllner, V; Tscheliessnigg, KH
A 10 min "No touch time" in Non-Heart Beating Donation - Is it enough?
The Scandinavian Transplantation Society XXVI Congress; May 9 - 11, 2012; Reykjavik, Iceland. 2012.
[Poster]
Stiegler, P; Sereinigg, M; Puntschart, A; Tscheliessnigg, KH; Stadlbauer-Köllner, V
Attitude towards xenotransplantation of patients prior and after human organ transplantation.
The Scandinavian Transplantation Society XXVI Congress; May 9 - 11, 2012; Reykjavik, Iceland. 2012.
[Poster]
Tripolt, NJ; Leber, B; Blattl, D; Eder, M; Wonisch, W; Stojakovic, T; Obermayer-Pietsch, B; Wascher, T; Pieber, T; Stadlbauer, V; Sourij, H
Impact of probioiics-supplementation on insulin sensitivity, beta-cell function and markers of endothelial function and inflammation in subjects with metabolic syndrome
Abstactbook. 2012; -European Atherosclerosis Society-EAS; MAY 25-28, 2012; Milano, ITALY.
[Poster]
FullText
Tripolt NJ, Leber B, Blattl D, Eder M, Wonisch W, Stojakovic T, Obermayer-Pietsch B, Wascher TC, Pieber TR, Sourij H, Stadlbauer V
Impact of Lactobacillus casei Shirota supplementation on insulin sensitivity, beta-cell function and markers of endothelial function and inflammation in subjects with metabolic syndrome
Gut Microbiota in Health and Disease; SEP, 13-15, 2012; Maastricht, THE NETHERLANDS. 2012.
[Poster]
Wright, G; Blattl, D; Stiegler, P; Jalan, R; Stadlbauer, V
Pericyte activation and Cerebral Sequlae of Cirrhosis
HEPATOLOGY. 2012; 56: 1099A-1100A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
[Poster]
Web of Science
Wright, GAK; Blattl, D; Stiegler, P; Jalan, R; Stadlbauer, V
PERICYTE ACTIVATION AND CEREBRAL SEQULAE OF CIRRHOSIS
J HEPATOL. 2012; 56: S237-S237.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(12)60610-2
[Oral Communication]
Web of Science
FullText
FullText_MUG
Leber, B; Stadlbauer, V; Stiegler, P; Stanzer, S; Mayrhauser, U; Köstenbauer, S; Leopold, B; Sereinigg, M; Puntschart, A; Stojakovic, T; Tscheliessnigg, KH; Öttl, K
Effect of oxidative stress and endotoxin on albumin in brain death
European Surgery. 2011; 43(242):41-41.-25th Annual Meeting of the Austrian Society of Transplantation.; Oct 19-22, 2011; Graz, Austria.
[Poster]
Oettl, K; Stadlbauer, V; Spindelboeck, W; Brtnik, M; Stauber, RE
Oxidative modification and high levels of bilirubin impair binding properties of albumin in advanced liver disease.
International Symposium on Albumin Dialysis; SEP 16-18, 2011; Rostock-Warnemünde, GERMANY. 2011.
[Oral Communication]
Sereinigg, M; Puntschart, A; Bradatsch, A; Stadlbauer-Köllner, V; Seifert-Held, T; Wiederstein-Grasser, I; Tscheliessnigg, KH; Stiegler, P
Establishing a brain death donor model in pigs
Transplant International, Supplement 2. 2011; 24: 275-275.-15th Conference of the European Society for Organ Transplantation; Sept 4-7, 2011; Glasgow, UK.
[Poster]
Web of Science
Sereinigg, M; Stiegler, P; Stadlbauer, V; Müller, S; Koellner, W; Schweiger, M; Tscheliessnigg, KH; Freidl, W;
Attitude towards Xenotransplantation of Patients prior and after Human Organ Transplantation.
11th Conference of the International Society for Organ Donation and Procurement; Nov 27-30, 2011; Buenos Aires, Argentinia. 2011.
[Poster]
Sereinigg, M; Stiegler, P; Stadlbauer, V; Puntschart, A; Seifert-Held, T; Leber, B; Mayrhauser, U; Blattl, D; Zink, M; Tscheliessnigg, KH;
A 10 min "no touch time" in Non-Heartbeating Donation - is it enough?.
11th Conference of the International Society for Organ Donation and Procurement; Nov 27-30, 2011; Buenos Aires, Argentinia. 2011.
[Poster]
Sereinigg, M; Stiegler, P; Stadlbauer, V; Puntschart, A; Seifert-Held, T; Leber, B; Mayrhauser, U; Widerstein, I; Tscheliessnigg, KH;
Establishinh a brain death donor model in pigs.
11th Conference of the International Society for Organ Donation and Procurement; Nov 27-30, 2011; Buenos Aires, Argentinia. 2011.
[Poster]
Stadlbauer, V
Die Gastrointestinale Perfusionsstörung: Ischämie und Thrombose
Intensivmedizin 2011; Jun 15-18, 2011; Wien. 2011.
[Keynote lecture]
Stadlbauer V, Leber B, Stiegler P, Stanzer S, Mayrhauser U, Köstenbauer S, Sereinigg M, Puntschart A, Stojakovic T, Tscheliessnigg K, Oettl K
Interactions of endotoxin, albumin function, albumin binding capacity and oxidative stress in brain-dead organ donors
Critical Care. 2011; 15(1):P524--ISICEM; Mar 23-25 2011; Brusseles, BELGIUM.
[Poster]
Stadlbauer, V; Stiegler, P; Müller, S; Schweiger, M; Sereinigg, M; Tscheliessnigg, KH; Freidl, W
Attitude towards xenotransplantation of patients prior and after human organ transplantation.
European Surgery. 2011; 43(242):54-54.-25th Annual Meeting of the Austrian Society of Transplantation.; Oct 19-22, 2011; Graz, Austria.
[Poster]
FullText
Stadlbauer, V; Stiegler, P; Täubl, P; Sereinigg, M; Puntschart, A; Bradatsch, A; Curcic, P; Seifert-Held, T; Zmugg, G; Stojakovic, T; Leopold, B; Blattl, D; Horki, V; Mayrhauser, U; Wiederstein-Grasser, I; Leber, B; Jürgens, G; Tscheliessnigg, KH; Hallström, S
Kein Unterschied im Gehalt an energiereichen Phosphaten in Organen von Lebendspendern, hirntoten Spendern und "non-heartbeating" Spendern im Tiermodell.
European Surgery. 2011; 43(242):8-9.-25th Annual Meeting of the Austrian Society of Transplantation.; Oct 19-22, 2011; Graz, Austria.
[Oral Communication]
FullText
Stadlbauer, V; Wallner, S; Stojakovic, T; Smolle, KH
Comparison of three different multi-analyte point-of-care devices during clinical routine on a medical ICU.
Critical Care. 2011; 15(1):P132--ISICEM; Mar 23-25 2011; Brusseles, BELGIUM.
[Poster]
Stiegler, P; Sereinigg, M; Leber, B; Mayrhauser, U; Köstenbauer, S; Stanzer, S; Puntschart, A; Leopold, B; Oettl, K; Tscheliessnigg, KH; Stadlbauer-Köllner, V
Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donation.
Transplant International, Supplement 2. 2011; 24: 276-276.-15th Conference of the European Society for Organ Transplantation; Sept 4-7, 2011; Glasgow, UK.
[Poster]
Web of Science
Stiegler, P; Sereinigg, M; Leber, B; Stadlbauer, V; Stanzer, S; Mayrhauser, U; Koestenbauer, S; Leopold, B; Puntschart, A; Stojakovic, T; Tscheliessnigg, KH; Oettl, K;
Effect of oxidative Stress and Endotoxin on human serum albumin in Brain-Dead Organ Donors.
11th Conference of the International Society for Organ Donation and Procurement; Nov 27-30, 2011; Buenos Aires, Argentinia. 2011.
[Poster]
Stiegler, P; Sereinigg, M; Puntschart, A; Stadlbauer-Köllneer, V; Müller, S; Tscheliessnigg, KH; Freidl, W
Attitude towards Xenotransplantation of Patients prior and after Human Organ Transplantation
Transplant International, Supplement 2. 2011; 24: 246-247.-15th Conference of the European Society for Organ Transplantation; Sept 4-7, 2011; Glasgow, UK.
[Poster]
Web of Science
Stiegler, P; Sereinigg, M; Stadlbauer, V; Puntschart, A; Seifert-Held, T; Leber, B; Mayrhauser, U; Blattl, D; Leopold, B; Hallstroem, S; Tscheliessnigg, KH
High Energy Phosphate Levels in different donor types.
11th Congress of the International Society for Organ Donation and Procurement; Nov 27-30, 2011; Buenos Aires, Argentinia. 2011.
[Poster]
Stiegler, P; Sereinigg, M; Stadlbauer, V; Puntschart, A; Seifert-Held, T; Tscheliessnigg, KH;
Establishing a Non-Heart-Beating Donor (NHBD) Model in pigs.
11th Conference of the International Society for Organ Donation and Procurement; Nov 27-30, 2011; Buenos Aires, Argentinia. 2011.
[Poster]
Stiegler, P; Sereinigg, M; STadlbauer-Köllner, V; Puntschart, A; Bradatsch, A; Curcic, P; Seifert-Held, T; Stojakovic, T; Leopold, B; Blattl, D; Mayrhauser, U; Leber, B; Köstenbauer, S; Hallström, S; Tscheliessnigg, KH
Influences of the donor type on organ energy status: Living versus Brain Dead versus Non-Heart Beating Donor.
Transplant International, Supplement 2. 2011; 24: 321-321.-15th Conference of the European Society for Organ Transplantation; Sept 4-7, 2011; Glasgow, UK.
[Poster]
Web of Science
Tripolt, NJ; Leber, B; Blattl, D; Eder, M; Pieber, TR; Stadlbauer, V; Sourij, H;
Impact of Lactobacillus casei Shirota supplementation on insulin
sensitivity and beta cell function in subjects with metabolic syndrome
Diabetologia (2011) . 2011; 54 (Suppl1): 251-251.-47th EASD Annual Meeting of the European Association for
the Study of Diabetes; SEP 12-16, 2011; Lissabon, Portugal.
[Poster]
FullText
Tripolt, NJ; Leber, B; Blattl, D; Eder, M; Wascher, TC; Pieber, TR; Stadlbauer, V; Sourij, H
Auswirkungen einer Lactobacillus casei Shirota Verabreichung auf Insulinsensitivität und Beta-Zellfunktion bei Patienten mit metabolischem Syndrom.
Aktuel Ernahrungsmed2011; 36(3):-10. Dreiländertagung der - Österreichischen Arbeitsgemeinschaft Klinische Ernährung (AKE), - der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) - und der Gesellschaft für Klinische Ernährung der Schweiz (GESKES)
; MAY 26-28, 2011; Graz, AUSTRIA.
[Poster]
FullText
Tripolt, NJ; Leber, B; D. Blattl2, Eder, M; Pieber,TR; Stadlbauer,V; Sourij, H;
Impact of Lactobacillus casei Shirota supplementation on insulin sensitivity and beta cell function in subjects with metabolic syndrome
Abstracts EASD 2011, Diabetologia. 2011; -EASD Annual Meeting; SEPT 12-16, 2011; Lisbon, Portugal.
[Poster]
V. Stadlbauer
Workshop Alcoholic Hepatitis
European Young Hepatologist Workshop; OCT 6-8, 2011; Bendor, FRANCE. 2011.
[Oral Communication]
Koestenbauer, S; Stiegler, P; Stadlbauer, V; Mayrhauser, U; Leber, B; Schweiger, M; Wasler, A; Prenner, G; Sereinigg, M; Zelzer, S; Stojakovic, T; Scarpatetti, M; Griesbacher, A; Greilberger, J; Tscheliessnigg, KH.
Myeloperoxidase and carbonyl proteins: Hopeful markers for non-invasive monitoring after heart transplantation concerning graft rejection
European Surgery2010; 42(237):57-57.-24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCt 27-29, 2010; Villach, Austria.
[Poster]
Koestenbauer, S; Stiegler, P; Stadlbauer, V; Mayrhauser, U; Leber, B; Schweiger, M; Wasler, A; Prenner, G; Sereinigg, M; Zelzer,S; Stojakovic, T; Scarpatetti, M; Griesbacher, A; Greilberger, J; Tscheliessnigg, KH
Myeloperoxidase and carbonyl proteins are promising markers for non-invasive monitoring after heart transplantation concerning graft rejection
European Surgery Suppl 2010; 42(238):7-8.-34th Seminar of the Austrian Society for Surgical Research; NOV 11-13, 2010; Wagrain, Austria.
[Oral Communication]
Leber, B; Stadlbauer, V; Stiegler, P; Stanzer, S; Mayrhauser, U; Koestenbauer, S; Leopold, B; Sereinigg, M; Puntschart, A; Stojakovic, T; Tscheliessnigg, KH; Oettl, K
Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donors.
Suppl 238/10
european surgery (Acta Chirurgica Austriaca)2010; -34th Seminar of the Austrian Society for Surgical Research; NOV 11-13, 2010; Wagrain, AUSTRIA.
[Oral Communication]
Macnaughtan, J; Davies, N; Stadlbauer, V; Damink, SWO; Mookerjee, RP; Jalan, R
EVIDENCE FOR COMPARTMENTALISED ENDOTOXEMIA AND ITS EFFECT ON NEUTROPHIL FUNCTION IN THE PORTAL CIRCULATION IN CIRRHOSIS
HEPATOLOGY. 2010; 52(4): 46
Web of Science
Mayrhauser, U; Stiegler, P; Leber, B; Koestenbauer, S; Stadlbauer, V; Sereinigg, M; Tscheliessnigg, KH
Influence of preservation solutions and bile on a human biliary tract carcinoma cell line: An in-vitro study
Supplement 238/10 of European Surgery2010; 42: -34th Seminar of the Austrian Society for Surgical Research; Nov 11-13, 2010; Wagrain, AUSTRIA.
[Oral Communication]
Mayrhauser, U; Stiegler, P; Leber, B; Koestenbauer, S; Stadlbauer, V; Sereinigg, M; Tscheliessnigg, KH
Influence of preservation solutions and bile on a human biliary tract carcinoma cell line: An in-vitro study
European Surgery, Suppl 237/. 2010; 42: -24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; Oct 27-29; Villach, Austria.
[Poster]
FullText
Sereinigg, M; Stiegler, P; Schweiger M; Bradatsch, A; Puntschart, A; Seifert-Held, T; Zmugg, G; Marko, T; Greilberger, J; Hallstroem, S; Stadlbauer, V; Scarpatetti, M; Tsybrovskyy, O; Lackner, C; Tscheliessnigg, KH
Establishing a brain death donor model in pigs.
XXIII. International Congress of the Transplantation Society; Aug 15 - 19, 2010; Vancouver, Canada. 2010.
[Poster]
Stiegler, P; Koestenbauer, S; Stadlbauer, V; Sereinigg, M; Greilberger, J; Mayrhauser, U; Leber, B; Schweiger, M; Wasler, A; Prenner, G; Zelzer, S; Stojakovic, T; Scarpatetti, M; Tscheliessnigg KH
Myeloperoxidase and Carbonyl Protein: Markers for non-invasive monitoring of graft rejection after heart transplantation.
Proceedings of the XXIII. Conference of the International Transplant Society2010; -XXIII. Conference of the International Transplant Society; Aug 15-19, 2010; Vancouver, Canada.
[Poster]
Stiegler, P; Sereinigg, M; Pierer, E; Matzi, V; Schaffellner, S; Iberer, F; Renner, H; Maier, A; Greilberger, J; Lackner, C; Aigner, R; Hauser, O; Stadlbauer, V; Smolle-Jüttner, FM; Tscheliessnigg KH
Creation of a prevascularized site for cell transplantation in rats.
Proceedings of the XXIII. Conference of the International Transplant Society2010; -XXIII. Conference of the International Transplant Society; Aug 15-19, 2010; Vancouver, Canada.
[Poster]
Koestenbauer, S; Stiegler, P; Mayrhauser, U; Leber, B; Matzi, V; Pierer, E; Hauser, O; Schaffellner, S; Renner, H; Greilberger, J; Aigner, R; Maier, A; Lackner, C; Iberer, F; Smolle-Jüttner, FM; Tscheliessnigg, KH; Stadlbauer, V
Creation of a prevascularized site for cell transplantation in rats
Supplement 232 of european surgery2009; 41: -33rd Seminar of the Austrian Society for Surgical Research; NOV 19-21, 2009; Wagrain.
[Oral Communication]
Koestenbauer, S; Stiegler, P; Stadlbauer-Köllner, V; Hackl, F; Schaffellner, S; Iberer, F; Greilberger, J; Strunk, D; Zelzer, S; Lackner, K; Tscheliessnigg, KH
Porcine islet cell isolation for xenotransplantation:
An optimized method with minimized oxidative stress for the PIC.
Human gene therapy2009; 20(11):1480-1480.-4th annual congress of german society for stem cell research (GSZ); Combined Meeting; NOV 23-25, 2009; Hannover, Germany.
[Poster]
Web of Science
Leber, B; Stiegler, P; Mayrhauser, U; Koestenbauer, S; Stadlbauer, V; Tscheliessnigg, KH
Characterisation for radiofrequency ablation in a pig model
Supplement 232 of european surgery2009; 41: -33rd Seminar of the Austrian society for surgical Research; NOV 19-21, 2009; Wagrain.
[Oral Communication]
Mayrhauser, U; Stiegler, P; Leber, B; Koestenbauer, S; Stadlbauer, V; Tscheliessnigg, KH
Effect of temperature on hepatocytes and fibroblasts: important findings for radiofrequency ablation in hepatocellular carcinoma
Supplement 232/09 of European Surgery2009; 41: -33rd Seminar of the Austrian Society for Surgical Research; NOV 19-21, 2009; Wagrain .
[Oral Communication]
Oettl, K; Brtnik, M; Payerl, D; Stadlbauer, V; Stauber, RE
Oxidative modification and high levels of bilirubin impair binding properties of albumin in Advanced Liver Disease
FREE RADICAL RES. 2009; 43: 43-43.-SFRR-Europe Meeting 2009; AUG 26-29, 2009; Rome, ITALY.
[Oral Communication]
Web of Science
Oettl, K; Greilberger, J; Lamprecht, M; Stadlbauer, V; Stauber, RE; Frank, S; Marsche, G
Oxidative Modified Human Serum Albumin: New Aspects of a well Known Molecule.
Pteridines. 2009; 20: 28-29.-International Winter-Workshop on Clinical, Chemical and Biochemical Aspects of Pteridines; MAR 1-8, 2009; St.Christoph, AUSTRIA.
[Oral Communication]
Rybczynski, M; Leber, B; Smolle, KH; Stauber, R; Stadlbauer, V
Innate immune dysfunction in sepsis and acute-on-chronic liver failure
WIEN KLIN WOCHENSCHR. 2009; 121(1-2):A9-A9.-Wiener Intensivmedizinische Tage; FEB 11-14, 2009; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
Schaffellner, S; Stiegler, P; Iberer, F; Hackl, F; Hauser, O; Stadlbauer, V; Lackner, C; Tscheliessnigg, K
Xenotransplantation of microencapsulated porcine islet cells in diabetic rats
XENOTRANSPLANTATION. 2009; 16(5):426-427.-Joint Meeting of the International Pancreas and Islet Transplant Association (IPITA) and the International Xenotransplant Association (IXA).; OCT 12 - 16, 2009; Venice, Italy.
[Poster]
Web of Science
Schaffellner, S; Stiegler, P; Iberer, F; Hackl, F; Hauser, O; Stadlbauer, V; Lackner, K; Tscheliessnigg, KH
Xenotransplantation of microencapsulated porcine islet cells in diabetic rats.
Xenotransplantation2009; 16(5):409-409.-Joint Meeting of the International Pancreas and Islet Transplant Association (IPITA) and the International Xenotransplantation Association (IXA); Oct 12-16, 2009; Venice, Italy.
[Poster]
Web of Science
Stiegler, P; Matzi, V; Pierer, E; Hauser, O; Schaffellner, S; Renner, H; Greilberger, J; Aigner, R; Maier, A; Lackner, C; Iberer, F; Smolle-Jüttner, FM; Stadlbauer, V; Tscheliessnigg, KH
Creation of a prevascularized site for cell transplantation in rats.
European Surgery, Supll 213/092009; 41: 18-18.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; Oct 21-23, 2009; Seefeld, Austria.
[Oral Communication]
Stiegler, P; Schaffellner, S; Stadlbauer, V; Hauser, O; Lackner, C; Hackl, F; Iberer, F; Tscheliessnigg, KH
Xenotransplantation of microencapsulated porcine islet cells in diabetic rats.
European Surgery2009; 41: 28-28.-50th Annual Meeting of the Austrian Society of Surgery; June 18-20, 2009; Vienna, AUSTRIA. (ISBN: 1682-8631 )
[Oral Communication]
Stiegler, P; Schweiger, M; Haid, M; Stadlbauer, V; Wasler, A; Schaffellner, S; Iberer, F; Tscheliessnigg, KH
The influence of mTOR inhibitors on CMV recurrence after whole organ transplantation.
European Surgery, Suppl 231/092009; 41: 13-12.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; Oct 21-23, 2009; Seefeld, Austria.
[Oral Communication]
Stiegler, P; Schweiger, M; Köstenbauer, S; Stadlbauer, V; Mayrhauser, U; Leber, B; Wasler, A; Zelzer, S; Stojakovic, T; Scarpatetti, M; Greilberger, J; Tscheliessnigg, KH
Myeloperoxidase and carbonyl proteins as serum markers of non-invasive monitoring of graft rejection in patients after heart transplantation.
European Surgery, Suppl 231/2009; 41: 7-7.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; Oct 21-23, 2009; Seefeld, Austria.
[Oral Communication]
Stiegler, P; Schweiger, M; Stadlbauer, V; Pierer, E; Matzi, V; Schaffellner, S; Renner, H; Maier, A; Greilberger, J; Lackner, C; Smolle-Jüttner, FM; Iberer, F; Tscheliessnigg, KH
Creation of a prevascularized site for pancreatic islet cell transplantation using a V.A.C.-GranuFoam and hyperbaric oxygenation in rats.
Transplant International2009; 22(2):221-221.-ESOT, European Society of Organ Transplantation; Aug 28-Sept 2, 2009; Paris, FRANCE.
[Poster]
Web of Science
Stiegler, P; Stadlbauer, V; Schaffellner, S; HAckl, F; Lackner, C; Iberer, F; Tscheliessnigg, KH
Xenotransplantation of microencapsulated porcine islet cells in diabetic rats.
Transplant International2009; 22(2):221-222.-ESOT, European Society of Organ Transplantation; Aug 28-Sept 2, 2009; Paris, FRANCE.
[Poster]
Web of Science
Stiegler, P; Stadlbauer, V; Schaffellner, S; Matzi, V; Maier, A; Renner, H; Lackner, C; Smolle-Juttner, FM; Iberer, F; Tscheliessnigg, K
Creating a prevascularized site for islet transplantation using a VAC (R)-GranuFoamTM and HBO in rats
XENOTRANSPLANTATION. 2009; 16(5):427-427.
[Poster]
Web of Science
Stiegler, P; Stadlbauer, V; Schaffelner, S; Koestenbauer, S; Mayrhauser, U; Leber, B; Halwachs, G; Hauser, O; Iberer, F; Lackner, C; Tscheliessnigg, KH;
Xenotransplantation of microencapsulated porcine islet cells in diabetic rats
Supplemet 232/09 of European Surgery2009; -33rd Seminar of the Austrian Society for Surcical Research; NOV 19-21, 2009; Wagrain, Austria .
[Oral Communication]
Stiegler, Ph; Stadlbauer, V; Schaffellner, S; Matzi, V; Maier, A; Renner, H; Lackner, C; Smolle-Jüttner, FM; Iberer, F; Tscheliessnigg, KH
Creating a prevascularized site for islet transplantation using a V.A.C. - Granufoam and HBO in rats.
Xenotransplantation2009; 16(5):409-409.-Joint Meeting of the International Pancreas and Islet Transplant Association (IPITA) and the International Xenotransplantation Association (IXA); Oct 12-16, 2009; Venice, Italy.
[Poster]
Web of Science
Tritto, G; Frances, R; Shah, N; Stadlbauer, V; Davies, N; Mookeriee, RP; Such, J; Jalan, R
PLASMA FROM STABLE PATIENTS WITH CIRRHOSIS TRANSMITS SEVERE NEUTROPHIL PHAGOCYTIC DYSFUNCTION WHICH IS INDEPENDENT OF THE PRESENCE OF BACTERIAL DNA AND ASSOCIATED WITH INCREASED EXPRESSION OF TLR-4
HEPATOLOGY. 2009; 50(4):19--The 60th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2009;
[Poster]
Web of Science
Davies, N; Stadlbauer, V; Mookerjee, RP; Jalan, R
SYNERGISTIC ALBUMIN THERAPY WITH ENDOTOXIN BINDING IMPROVES IMMUNE CELL RESPONSE AND SYSTEMIC FUNCTION IN A MODEL OF ACUTE-ON-CHRONIC LIVER FAILURE
HEPATOLOGY. 2008; 48(4):312--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA.
[Poster]
Web of Science
Duller, D; Haas, J; Stadlbauer, V; Kniepeiss, D; Palma, S; Gurakuqi, G; Gallent, HR; Iberer, E; Stauber, RE
The LB model: A new prognostic tool for prediction of short term survival in patients with end stage liver disease
J HEPATOL. 2008; 48: S81-S81.-EASL - Meeting of the European Society for Liver Disease; APR 23-26; Milan, ITALY.
Doi: 10.1016/S0168-8278(08)60194-4
[Poster]
Web of Science
FullText
FullText_MUG
Duller, D; Haas J., Stadlbauer V., Palma St., Gallent H., Kniepeiss D., Smolle KH., Stauber RE
The LB Model: a New Prognostic Tool for Prediction of Short Term Survival in Patients with End-Stage Liver Disease
Liver Transplantation Supplement of the Meeting of the International Society of Liver Transplantation2008; 14(S1):S201-S202.-ILTS Meeting of the international liver transplant society 2008; JUL 12-14; Paris, France.
[Poster]
Web of Science
Mookerjee, RP; Lackner, C; Stadlbauer, V; Deheragoda, M; Jalan, R
Early liver biopsy is crucial for accurate diagnosis of alcoholic hepatitis and provides independent prognostic information in patients with decompensated alcoholic liver disease
J HEPATOL. 2008; 48: S356-S357.-43rd Annual Meeting of the European Association for the Study of Liver; APR 23 - 27, 2008;
Doi: 10.1016/S0168-8278(08)60955-1
[Poster]
Web of Science
FullText
FullText_MUG
Mookerjee, RP; Lackner, C; Stadlbauer, V; Williams, R; Jalan, R
Early liver biopsy is crucial for accurate diagnosis of alcoholic hepatitis and provides independent prognostic information in patients with decompensated alcoholic liver disease
GUT. 2008; 57: A39-A39.-43rd Annual Meeting of the European Association for the Study of Liver; APR 23 - 27, 2008;
[Poster]
Web of Science
Stadlbauer, V; Mookerjee, R; Wright, G; Hodges, S; Jalan, R
Restoration of the defective innate immune system following treatment with the probiotic Lactobacillus casei Shirota in patients with alcoholic cirrhosis: A proof of concept study
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A44-A44.
[Poster]
Web of Science
Stiegler, P; Schweiger, M; Greilberger, J; Marko, T; Hallström, S; Lackner, C; Iberer, F; Tscheliessnigg, KH
Prevention of oxidative stress induced organ damage in a porcine brain dead donor model.
European Surgery2008; 40: 36-36.-Austrotransplant 2009; Oct 29-31, 2008; Zell am See, Austria.
[Oral Communication]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Greilberger, J; Hackl, F; Iberer, F; Matzi, V; Smolle-Jüttner, FM; Lackner, C; Tscheliessnigg, KH
DOES HYPERBARIC PRE - OXYGENATION HAVE A POSITIVE EFFECT ON PORCINE PANCREAS PRESERVATION?
Scandinavian Transplant Society; May 14-16, 2008; Oslo, Sweden. 2008.
[Poster]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Hackl, F; Greilberger, J; Lackner, C; Iberer, F;Tscheliessnigg, KH;
Modifications of the automated Ricordi method
for the prevention of oxidative stress
in the isolation of porcine pancreatic islet cells
Scandinavian Transplant Society; May 14-16, 2008; Oslo, Sweden. 2008.
[Oral Communication]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Iberer, F; Lackner, C; Hauser, O; Tscheliessnigg, KH
Xenotransplantation of microencapsulated porcine islet cells in diabetic rats
Europ J Surgery2008; -Austrotransplant; Oct 29-31, 2008; Zell am See, Austria.
[Oral Communication]
Schaffellner, S; Stiegler, P; Stadlbauer, V; Greilberger, J; Hackl, F; Iberer, F; Lackner, C;Tscheliessnigg, KH
Modification of standard isolation procedures increases yield, purity and viability of porcine islet cells (PIC)
Xenotransplantation. 2007; 14(5):512-512.-Joint Meeting of the International Xenotransplantation Association (IXA), the International Pancreas and Islet Transplantation Association (IPITA), and the Cell Transplantation Society (CTS); SEPT 15-20; Minneapolis, USA.
[Poster]
Web of Science
Stiegler, P; Pierer, E; Schaffellner, S; Matzi, V; Aigner, R; Renner, H; Maier, A; Iberer, F; Lackner, C; Smolle-Jüttner, FM; Tscheliessnigg, KH;
Transplantation and characterisation of 293-Luc cells microencapsulated in Sodium Cellulose Sulfate in a prevascularized site in rats.
European Surgery, Acta Chirurgica Austriaca2007; 39: 37-37.-Austrotransplant; Oct 17 - 20, 2007; St. Wolfgang.
[Poster]
Stiegler, P; Pierer, E; Schaffellner, S; Matzi, V; Aigner, R; Renner, H; Maier, A; Stadlbauer, V; Smolle-Jüttner, FM; Lackner, C; Iberer, F; Tscheliessnigg, KH
DOES HYPERBARIC OXYGENATION (HBO) HAVE A POSITIVE EFFECT ON PORCINE PANCREAS PRESERVATION?
. 2007; 20: 168-168.
[Poster]
Web of Science
Stiegler, P; Stadlbauer, V; Schaffellner, S; Greilberger, J; Hackl, F; Iberer, F; Tscheliessnigg, KH
MODIFICATION OF STANDARD ISOLATION PROCEDURES INCREASES YIELD, PURITY AND VIABILITY OF PORCINE ISLETS OF LANGERHANS
Transplant International. 2007; 20: 168-168.-13 th Conference of the European Society for Organ Transplantation (ESOT); Sept 30 - Okt 04; Prag, Tschechische Republik.
[Poster]
Web of Science
Stiegler, P; Stadlbauer, V; Schaffellner, S; Iberer, F; Lackner, C; Tscheliessnigg, KH
A modified Ricordi method for the prevention of oxidative stress in the isolation of porcine pancreatic islet cells.
European Surgery, Acta Chirurgica Austriaca2007; 39: 37-37.-Austrotransplant; Oct 17 - 20, 2007; St. Wolfgang.
[Oral Communication]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Matzi, V; Pierer, E; Aigner, R; Smolle-Jüttner, FM; Lackner, C; Renner, H; Greilberger, J; Iberer, F; Tscheliessnigg, KH
Creating a prevascularized site for islet transplantation using a V.A.C. ¿ Granufoam and HBO in rats
. 2007; 14(5): 512-512.
[Poster]
Web of Science
Stiegler, P; Stadlbauer, V; Schaffellner, S;Hauser, O; Lackner, C; Iberer, F; Tscheliessnigg, KH
SODIUM CELLULOSE SULFATE (NaCS) AS A NOVEL METHOD FOR MICROENCAPSULATION OF PANCREATIC CELLS
Konferenzband. 2007; -13th Congress of the European Society for Organ Transplantation (ESOT); Sept 30 - Okt 04; Prag, Tschechische Republik.
[Poster]
Stiegler, P; Stadlbauer, V;,Schaffellner, S; Matzi, V; Pierer, E; Aigner, R; Smolle-Jüttner, FM; Lackner, C; Greilberger, J; Iberer, F; Tscheliessnigg, KH
CREATING A PREVASCULARISED SITE FOR ISLET TRANSPLANTATION USING A V.A.C. GranuFoam AND HBO IN RATS
Konferenzband. 2007; -13th Conference of the European Society for Organ Transplantation (ESOT) ; Sept 30 - Okt 04; Prag, Tschechische Republik.
[Poster]
Stiegler, PB; Stadlbauer, V; Schaffellner, S; Lackner, C; Iberer, F; Tscheliessnlgg, K
Sodium cellulose sulfate (NaCS) as a novel method for microencapsulation of pancreatic cells
TRANSPLANT INT. 2007; 20: 168-168.
[Oral Communication]
Web of Science
Graziadei, IW; Nilica, B; Stadlbauer, V; Stauber, R; Trauner, M; Mueller, C; Vogel, W
Imatinib treatment for patients with advanced stage hepatocellular carcinoma: A multicenter phase II trial
HEPATOLOGY. 2006; 44(4):503A-504A.
[Poster]
Web of Science
Oettl, K; Greilberger, J; Stadlbauer, V; Petter, F; Lackner, C; Putz-Bankuti, C; Stauber, R
Redox state of serum albumin and carbonyl content of plasma proteins in advanced liver disease
FREE RADICAL RES. 40: S151-S151.-13 th Biennal Congress, Society for Free Radical Research-International; AUG 15-19, 2006; Davos, Switzerland.
[Poster]
Web of Science
Oettl, K; Stadlbauer, V; Petter, F; Greilberger, J; Putz-Bankuti, C; Lackner, K; Stauber, R
Redox state of human serum albumin in liver disease
FEBS Journal. 273(1):164-164.-31 st FEBS Congress, Molecules in Health and Disease; JUN 24-29, 2006; Istanbul, Turkey.
[Poster]
Web of Science
Schneditz, D; Bachler, I; Stadlbauer, V; Stauber, R
Continuous and non-invasive measurement of circulatory function during paracentesis of tense ascites
Wissenschaftliche Gesellschaft der Ärzte in der Steiermark; Apr 6, 2006; Graz, AUSTRIA. 2006.
[Oral Communication]
Schweiger, M; Wasler, A; Prenner, G; Stiegler, P; Stadlbauer, V; Schwarz, M; Tscheliessnigg, KH
Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients
American Journal of Transplantation. -World Transplant Congress, Boston, MA, USA, 2006; Julie; Boston, USA.
[Poster]
Schweiger, M; Wasler, A; Stiegler, P; Prenner, G; Tripolt, M; Schwarz, M; Stadlbauer, V; Tschleiessnigg, KH
Reduzierte CsA Talspiegel in Kombination mit Everolimus vs. Konventionellem Immunsuppressivem Schema nach HTX
-Jahrestagung der Österreichischen Gesellschaft für Organtransplantation und Transfusionsmedizin; Oktober ; Fuschl.
[Oral Communication]
Stauber, RE; Oettl, K; Stadlbauer, V; Greilberger, J; Krisper, P; Lackner, C
Redox state of albumin and carbonyl content of proteins are altered in acute-on-chronic liver failure
HEPATOLOGY. 44(4):364A-365A.-57th Annual meeting of the AASLD; OCT 27-31, 2006; Boston, USA.
[Poster]
Web of Science
Stauber, RE; Stadlbauer, V; Struber, G; Kaufmann, P
Evaluation of four prognostic scores in patients with acute-on-chronic liver failure
J HEPATOL. 44: S69-S70.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(06)80166-2
[Poster]
Web of Science
FullText
FullText_MUG
Stiegler, P; Matzi, V; Schaffellner, S; Stadlbauer, V; Klemen, H; Lackner, C; Smolle-Jüttner, FM; Pierer, E; Iberer, F; Tscheliessnigg, KH
Creating a prevascularized site for islet transplantation using a VAC-GranuFoam and HBO in rats.
European Surgery. Abstracts of the 47th annual meeting of the Austrian Society of Surgery; 38(209):15-15.-47 Annual meeting of the Austrian Society of Surgery; JUN 15 - 17; Vienna. (ISBN: 03Z0-35236 )
[Oral Communication]
Stiegler, P; Schaffellner, S; Matzi, V; Klemen, H; Stadlbauer, V; Greilberger, J; Hallström, S; Smolle-Juettner, FM; Lackner, C; Hackl, F; Iberer, F; Tscheliessnigg, KH
Does hyperbaric oxygenation (HBO) have a positive effect on porcine pancreas preservation?
European Surgery. Abstracts of the 47th Annual Meeting of the Austrian Society of Surgery; 38(209):106-107.-47th Annual Meeting of the Austrian Society of Surgery; JUN 15 - 17; Vienna, Austria. (ISBN: 03Z0-35236 )
[Poster]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Halwachs, G; Lackner, C; Hackl, F; Iberer, F; Tscheliessnigg, KH
Evaluation of different preservation solutions with or without HBO for pancreas preservation for islet isolation.
-ESAO 2006; June 2006; Umea, Sweden.
[Oral Communication]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Halwachs, G; Lackner, C; Matzi, V; Renner, H; Greilberger, J; Somolle-Jüttner, FM; Iberer, F; Tscheliessnigg, KH
Creating a prevascularised site for islet transplantation using a V.A.C.®-GranuFoam and HBO in rats.
6th International Meeting of the Cell Transplantation Society.; Mailand, Italy. 2006.
[Oral Communication]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Lackner, C; Iberer, F; Hackl, F; Tscheliessnigg, KH
The influence of different freezing media on insulin-producing cells encapsulated with Sodium Cellulose Sulfate (NaCS).
6th Congress of the International Cell Transplantation Society; Oct 3-6; Mailand, Italy. 2006.
[Poster]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Matzi, V; Lackner, C; Hackl, F; Iberer, F; Tscheliessnigg, KH
Tscheliessnigg Evaluation of different preservation solutions with or without HBO for pancreas preservation for islet isolation.
Conference of the European Society of Artificial Organs (ESAO)
; June 2006.; 2006.
[Oral Communication]
FullText
Stojakovic, T; Putz-Bankuti, C; Fauler, G; Gurakuqi, G; Scharnagl, H; Stadlbauer, V; Stauber, R; Maerz, W; Trauner, M
Atorvastatin in patients with primary biliary cirrhosis and incomplete response to ursodeoxycholic acid.
Clin Chem Lab Med. 44(9):A207-A207.-First Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC); OCT 4-7, 2006; Salzburg, Austria.
[Poster]
Wimmer, J; Bachler, I; Haditsch, B; Stadlbauer, V; Holzer, H; Schneditz, D
Device and technique for extracorporeal blood volume sequestration during hemodialysis (HD)
INT J ARTIF ORGANS. 29: 525-525.-XXXIII Congress of the European Society for Artificial Organs (ESAO); JUNE 20-21, 2006; Umeå, SWEDEN.
[Oral Communication]
Web of Science
Krisper, P; Stadlbauer, V; Haditsch, B; Holzer, H; Trauner, M; Stauber, RE; Schneditz, D
The bilirubin/albumin ratio does not influence the clearance of conjugated bilirubin in extracorporeal liver support (ELS)
NEPHROL DIALYSIS TRANSPLANT. 2005; 20: V117-V117.-42nd Annual Meeting of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA); JUN 04-07, 2005; Istanbul, TURKEY.
Web of Science
Schaffellner, S; Stiegler, P; Stadlbauer, V; Iberer, F; Hauser, O; Tscheliessnigg KH
Experiences with Sodium Cellulose Sulfate (NaCS) for microencapsulation of islet cells
AIDPIT; Igls, Austria. 2005.
[Poster]
Schaffelner, S; Stiegler, P; Stadlbauer, V; Halwachs, G; Hauser, O; Iberer, F; Lackner, K; Tscheliessnigg, KH
Sodium Cellulose Sulfate (NaCS) as a novel method for microencapsulation of pancreatic cells
Conference of the International Pancreas and Islet Transplantation Association (IPITA); Genf, Scheiz. 2005.
[Oral Communication]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Halwachs, G; Lackner, C; Hauser, O; Iberer, F; Tscheliessnigg, K
Microencapsulation of porcine pancreas cells with sodium cellulose sulfate (NaCS) to create a bioartificial pancreas
XENOTRANSPLANTATION 2005 12: 399-399.
Web of Science
Stiegler, P; Stadlbauer, V; Schaffellner, S; Hauser, O; Lackner, C; Iberer, F; Tscheliessnigg, KH
The influence of different freezing media on insulin-producing cells encapsulated with Sodium Cellulose Sulfate (NaCS)
International Pancreas and Islet Transplantation Association (IPITA); Genf, Schweiz. 2005.
[Poster]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Iberer, F; Lackner, C; Hauser, O; Tscheliessnigg, KH
Microencapsulation of porcine pancreas cells with sodium cellulose sulfate (NaCS) to create a bioartificial pancreas
15th Interdisciplinary Research Conference on Biomaterials (IRCB); March 18 - 20, 2005; Shanghai, China. 2005.
[Oral Communication]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Iberer, F; Lackner, C; Hauser, O; Tscheliessnigg, KH
Microencapsulation of insulin producing cells with NaCS to create a bioartificial pancreas
International Society for Cellular Therapy ; Vancouver, Canada. 2005.
[Oral Communication]
Stiegler, P; Stadlbauer, V; Schaffellner, S; Matzi, V; Klemen, H; Smolle-Juttner, F; Hackl, F; Halwachs, G; Lackner, C; Iberer, F; Tscheliessnigg, K
Hyperbaric oxygenation and porcine islet isolation
XENOTRANSPLANTATION 2005 12: 399-400.
Web of Science
Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Stadlbauer, V; Gurakuqi, G; Stauber, RE; März, W; Trauner, M
Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
35. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2005; Maikammer, Deutschland. 2005.
[Oral Communication]
Kniepeiss, D; Iberer, F; Schaffellner, S; Jakoby, E; Stadlbauer, V; Tscheliessnigg, KH
Single center experience with retrograde reperfusion in liver transplantation
LIVER TRANSPLANT 2003 9: C16-C16.
Web of Science
Schaffellner, S; Hoess, G; Rigler, M; Puchinger, M; Kniepeiss, D; Stadlbauer, V; Iberer, F; Kohek, P; Tscheliessnigg, KH
Hyperthermia in a Patient with Relapse of HCC after LTX.
Proceeding Book 2003; 232-233.-14th International Congress on Anti-Cancer Treatment; FEB 1-4, 2003; Paris, France.
[Poster]
Stadlbauer, V; Stiegler, P; Schaffellner, S; Halwachs, G; Iberer, F; Tscheliessnigg, KH
Microencapsulation of pancreas islet cells: Cellulose sulphate as a promising new material
XENOTRANSPLANTATION 2003 10: 523-523.
Web of Science
Lackner, C; Stadlbauer, V; Stindl, G; Mischinger, HJ; Denk, H; Zatloukal, K
Overexpression of keratin 8- and 18 mRNA in hepatocellular carcinoma.
HEPATOLOGY 1999 30: 324A-324A.
Web of Science